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Cage compounds have attracted pharmaceutical and biological interest amongst others as anti-
Parkinson agents.  The serendipitous observation of the activity of 1-aminoadamantane 1 in 
Parkinsonian patients against selected viruses i.e. Herpes simplex Type I & II and Influenza A2-
Asian viruses/Taiwan has increased the interest in cage compounds.  This study involves the 
synthesis of the cage amino acid 14.  Due to the insolubility of pentacyclo-[6.3.0.02,6.03,10.05,9]-
undecane (trishomocubane) amino acid 14 in both polar and nonpolar solvents, including DMSO 
(d6), the synthesis of Fmoc-tris amino acid 50 was required for analysis.  The Fmoc derivative of 
trishomocubane amino acid was also useful for controlled* coupling of the cage amino acid 14 to 
short peptides.  The synthesis of the Fmoc-tris amino acid fluoride derivative is described as well as 
that of the tri-peptide (Ala-Ala-Ala).  The incorporation of the Fmoc-tris amino acid fluoride in a 
tetra-peptide Ala-Ala-Ala-tris and in a hepta-peptide Ala-Ala-Ala-tris-Ala-Ala-Ala will also be 
presented. 
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A computational chemistry project was undertaken using density functional theory (B3LYP) at the 
6-31+G(d) level of theory, so as to enhance the understanding of the mechanism of esterification.  
Methanol, acetyl chloride and acetic acid were used in the model for simplicity.  Four membered 
ring transition states were obtained with both acetyl chloride and acetic acid.  A six membered ring 
transition state is facilitated by the selective use of one methanol molecule from the solvent.  Both a 
concerted and step-wise mechanism are presented.   
                                                                 
* Addition of N-protected amino acid ensures the controlled coupling of one amino acid segment to the peptide chain. 
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In recent years, saturated polycyclic “cage" molecules have attracted special attention from organic 
chemists.1, ,2 3  Most saturated cage molecules contain considerable strain energy due to unusually 
long carbon-carbon σ-bonds† in the cage framework and unusual C-C-C bond angles that deviate 
significantly from the normal ∼109.5°.  The adamantane “cage” is an exception with a carbon 
skeleton close to the perfect diamond structure.4,5  The strain energy in other cage moieties 
expresses itself through unusual patterns of chemical reactions. 
Polycyclic “cage” hydrocarbons are of interest in three areas of applied research: 
• As a potential new class of high energy or high-density fuels due to their highly strained 
structures.1,6,7  Cage compounds such as 6,6,10,10-tetranitropentacyclo-[5.3.0.02,6.03,10.05,9]- 
decanes are of interest as a potential new class of explosives and propellants.1, ,8 9 
• Pharmaceutical interest.4, , ,  10 11 12
• A relatively new field involving applications of chiral cage compounds as catalysts in 
asymmetric synthesis.13, , ,14 15 16 
Pharmacological interest in cage compounds abounded after it was serendipitously observed that 
amantadine (1-aminoadamantane) 1 was active as an anti-Parkinson agent when used to treat 
patients against influenza A2 Asian viruses.  Other amino functionalised cage compounds like 2 and 
3 have shown activity against selected viruses i.e. Herpes simplex Type I & II and Influenza A2.  
Two amino derivatives of (D3)-trishomocubane 3a and 3b were evaluated for their in vivo and in 
vitro activities and compared favourably with amantadine 1.  One of the derivatives 3a exhibited a 
great improvement on amantadine when used to protect mice against influenza A2.
17  
Parkinson’s disease was also known as (paralysis agitans) before it was described in 1817 by the 
London physician James Parkinson.18  It is a slowly progressive malady of the sixth and later 
decades of life, and James Parkinson’s description of this disease was that it is “involuntary 
tremulous motion, with lessened muscular power, in parts not in action and even when supported; 
with propensity to bend the trunk forwards, and to pass from a walking to a running pace, the senses 
and intellects being uninjured.” 
                                                                 




Figure 1: Amantadine (1-Aminoadamantane) 
The interest of the organic group at UKZN19 in cage molecules was stimulated by the biological 
and pharmaceutical properties of amino functionalised cage compounds such as 2 and 3:  
• as potential antiviral agents.  




3a    R' = R = CH2CH3
R' = H, R = CH2CH33b     
Figure 2: PCU and Trishomocubane amines 
Cage compounds have therefore found wide applications in drugs, since it was discovered that the 
incorporation of the cage skeleton enhances the transport of the drug across cell membranes, the 
blood brain barrier (BBB) and into the central nervous system (CNS).4,21  Drugs modified to 
include cage moieties experience an increased affinity for lipophilic regions in receptor molecules 
due to the hydrophobic/lipophilic nature of the cage skeleton.  It has been suggested that the 
increase in activity observed for cage-modified drugs is a direct result of an increase in drug 
delivery.4,21  A further advantage, conferred by the steric bulk of the cage skeleton, is the resistance 
of cage-modified drugs to metabolic degradation.  This increases the in vivo life time of the drug 
and reduces the frequency of drug administration to the patient.21,22  The research group at UKZN 
is currently using three different cage structures, namely pentacyclo-[5.4.0.02,6.03,10.05,9]-undecane 
(PCU, 4), a more stable isomer23 with the trivial name of trishomocubane 524 and the norbornane 6‡ 
/camphor 7‡ skeleton. 
The trishomocubane skeleton is intrinsically chiral, while the PCU skeleton is a (meso) compound 
that can be made chiral through asymmetric synthesis.  The camphor skeleton 7 is also a chiral 
compound while norbornane 6 is achiral (meso). 
                                                                 









Figure 3: Cage skeletons 
Chirality is an important phenomenon in biochemistry and in the pharmaceutical industry.25,26  The 
effect of chirality is observed in drugs, where a biologically active chiral compound (drug) interacts 
with a receptor site which is chiral.  Enantiomers of the drug interact differently and produce 
different effects.  Thalidomide 8 (a drug prescribed for morning sickness) is a good example, where 









Figure 4: (-)-Thalidomide 
Sessler et al.27 have demonstrated that (S)-amino acids are transported with greater affinity than the 
(R)-enantiomers in a lasalocid conjugate carrier.  Fujii et al.28 have shown that the opioid peptide, 
dermorphin, [Try-(R)-Ala-Phe-Gly-Try-Pro-Ser-NH2] loses its activity when (R)-Ala is substituted 
by the (S)-Ala enantiomer.  
One of the interests of the organic research group at UKZN is to incorporate unnatural cage α-
amino acids into peptides.  The pentacyclo-[5.4.0.02,6.03,10.05,9]-undecane amino acid 1129 and the 
pentacyclo-[6.3.0.02,6.03,10.05,9]-undecane amino acid (trishomocubane amino acid, 14)30,31 were 
synthesized from the corresponding monoketones 9 and 12 via hydantoin formation 





























(±)-13 (±)-14(±)-12  
Scheme 1: Synthesis of the cage amino acids 
The starting material for both monoketones 9 and 12 is readily obtained from the Diels-Alder 
reaction between p-benzoquinone 16 and cyclopentadiene 17.  The intramolecular [2 + 2] 
photocyclization reaction32 of 5,8-methano-4a,5,8,8a-tetrahydro-1,4-naphthoquinone (adduct, 18) 
yields Cookson's diketone 19.33,34  Cookson’s diketone 19 has formed the foundation for many 
studies about the chemistry of pentacycloundecyl compounds.  














Scheme 2: Synthesis of the adduct (18) and the Cookson’s diketone (19) 
The incorporation of the cage residue into non-natural peptides was investigated using molecular 
mechanics and (ab initio) computational methods.  It has been demonstrated35, , , ,36 37 38 39 that amino 
acids such as 11 and 14 induce an α-helix and strong β-turn effects in the peptide chain.  β-
turns35,36,37,40 play an important role in globular proteins from both structural and functional points 
of views.  Amongst the forces that control protein folding, β-turns comprise about 25% of all 
residues in proteins and are the most important motif for protein folding to produce their compact 
structure.41  A polypeptide chain cannot fold into a compact structure without the component of 
turns.  The turns (β-turns) usually occur on the exposed surface of proteins and hence probably 
represent antigenic sites or involve molecular recognition.42,43  β-turns provide useful information 
to define template structures for the design of new molecules such as drugs and pesticides.  
Therefore the prediction of β-turns in the secondary structure of proteins is an important element of 
computational analysis.36,43   
  4
Kruger’s research group has started a computational chemistry project44 to develop a computational 
model for esterification reactions.  Singh started an ambitious project to model the esterification 
reaction of the PCU amino acid 11, but it turned out that the development of a simpler model is 
required before the project can be concluded.  The trishomocubane amino acid 14 has previously 
been esterified,45 but the PCU amino acid 11 seems to be more resistant towards esterification.45,46
This investigation had the following objectives: 
• To synthesize the trishomocubane amino acid 14 in good yield.  
• To collaborate in a project to establish a procedure for the incorporation of the trishomocubane 
amino acid into a short peptide.  
• To develop a computational model that describes the mechanism of esterification of acids and 
acid chlorides with methanol.  This is required to explain (in future) the difference in reactivity 







Synthesis of (D3)-trishomocubane amino acid and its derivatives 
Amino acids are organic compounds which contain both carboxylic acid groups (-COOH) and 
amino groups (-NH2).  Alpha (α) amino acids are those with both the amino and carboxylic acid 
groups linked to the same α-carbon atom.  Amino acids are amphoteric compounds (Scheme 3) due 
to the acidic nature of the carboxylic acid group and the basic nature of the amino group.47,48  The 
R-groups play an important role by contributing to the amphipathic character of the amino acids.  
The R-groups make the amino acid more hydrophobic/lipophilic and the charged groups make it 
hydrophilic.  The interaction between hydrophobic residues in an aqueous environment enables the 














Scheme 3: The structure of amino acids is pH dependent.49
At physiological pH most natural amino acids are in the zwitterion form, making the amino acids 
more soluble in blood.  The natural occurring amino acids are made of C, H, O and N except 
cysteine and methionine which contain sulphur.50  Amino acids have attained a wide variety of 
commercial applications as ingredients in food and animal feed and as chiral building blocks for 
pharmaceuticals.  There is an increasing interest in optically pure (R)- and (S)-α-amino acids as 
precursors for semisynthetic antibiotics, new herbicides, insecticides, and physiologically active 
peptides.51  Amino acids are chiral§ molecules which, when in solution, induce (±)-rotation of 
plane-polarised light.  In nature amino acids appear predominantly in the (S)-form except for 
cysteine, the achiral glycine (Gly) and various non-common amino acids found in sea organisms 
and plants.  These (R)-amino acids are in many cases used in various types of chemical defense 
mechanisms.52  Asymmetric synthesis of these amino acids produces racemates.  The (-)-rotation 
which is counter-clockwise by definition is called “levorotatory” rotation whereas the (+)-rotation is 
clockwise and is called “dextrotatory” rotation.53   
                                                                 
§ The word chiral comes from the Greek word meaning handedness.  A chiral compound has a stereogenic centre (carbon with four 
different groups according to a simplified organic definition).   
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Chirality is demonstrated by the two alanine 21 enantiomers below.  Alanine can be obtained in two 
forms (S)-Ala-21 and (R)-Ala-21 which are mirror images.  The two mirror images have similar 
physical and chemical properties in the absence of an external chiral influence.  This implies that 
(S)-Ala-21 and (R)-Ala-21 have the same melting point, solubility, chromatographic retention time, 
infrared (IR) and nuclear magnetic resonance (NMR) spectra.   They differ physically only in that 












Figure 5: (R) and (S)-alanine 
In recent years there has been an increased interest in the preparation of novel unnatural amino acid 
derivatives to serve as building blocks in drugs.29,54  The work reported in this dissertation is based 
on artificial (non-proteinogenic) amino acids that are of great importance in pharmaceutical 
chemistry.  Based on the enhanced pharmaceutical properties of drugs attached to cage moieties,4,21 
cage amino acids have potential as a new class of bioactive compounds.  It was predicted35,36,38 that 
cage amino acids could be used in the field of peptide synthesis, where the hydrophobic side chains 
could potentially assist the peptide to cross the blood brain barrier.20,55  Synthesis of unnatural 
amino acids is important not only for the production of potentially useful compounds but also for 
the preparation of structural analogues, since in many cases only small quantities of active species 
are isolated from natural sources.54,56  
The strategy for the synthesis of the two amino acids 11 and 14 was adopted from the method used 














22 23 24  
Scheme 4: Synthesis of (2-aminoadamantane-2-carboxylic acid) (24) 
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Trishomocubane amino acid (tris-amino acid, 14) was first synthesized by Govender and Raasch et 
al.   It was first characterized as the Fmoc derivative due to its insolubility in organic solvents. 
As indicated in Chapter 1, the starting material for the tris-amino acid 14 is Cookson's diketone 19.   
The synthesis of 19 via a Diels-Alder reaction is presented in Scheme 2.  p-Benzoquinone 16 is 
recrystallized from dichloromethane/diethyl ether and dissolved in toluene/benzene.  Freshly 
cracked cyclopentadiene 17 is then added to yield 5,8-methano-4a,5,8,8a-tetrahydro-1,4-
naphthoquinone (adduct, 18). 
It was believed that the adduct 18 underwent photocyclisation via a [π2s+π2s] cyclisation 
“suprafacially” to yield the diketone 19.33,58  Recently Marchand et al.  used (ab initio) 
computational studies to demonstrate that the cyclisation of the adduct probably occurs via a 
stepwise diradical mechanism.  The mechanism proceeds through a triplet excited state rather than a 
suprafacial [π2s+π2s] cyclisation.  Kent et al.  also used computational modelling (force field 
calculations) to demonstrate that the PCU skeleton 25 is a kinetic product which can rearrange to 
the thermodynamically more stable trishomocubane 26. 
Force field calculations were used to demonstrate that the trishomocubane skeleton is ~10 
kcal.mol-1 more stable than the PCU moeiety.22,23,59   Kent et al.  used the reported values by 
Schleyer et al.  and Allinger et al.  to argue that the PCU skeleton can be used as an excellent 
starting material for the synthesis of trishomocubane related compounds, following a 1,2 alkyl shift 
of the intermediate secondary cation (Scheme 5).  They also calculated the stabilities of various 
carbocations and showed that a carbocation at C8 or C11 is more stable than any other possibility.  
This is also the only position of the carbocation on cage 25 which does not give rise to a structure 
with a three or four membered ring.  A cation at C9 may not be prohibitively strained but all 
possible 1,2 alkyl shifts lead to a four membered ring product.  A discussion of the computational 
studies executed by Raasch at UKZN on the rearrangement of the PCU alcohol 31 to 































Scheme 5: Rearrangement of PCU skeleton to trishomocubane 
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The intrinsically chiral trishomocubanone 12 is a key member and a useful intermediate for the 
synthesis of amino related compounds, as the carbonyl group provides a convenient “handle” for 












































Figure 6: (-) and (+)-Trishomocubanone  
Breakage of a single bond within a molecule is required to convert one stereogenic center into 
another.26,61  This principle is not applicable to the intrinsically chiral trishomocubane skeleton.  
The chirality of a molecule is sometimes ascribed to the presence of a chiral axis.  The same 
principle is applied to the (D3)-trishomocubane skeleton, where the chiral axis is a C3 axis through 
C2-C9.  The result is that the trishomocubane skeleton resembles either a left handed or right 
handed propeller (Figure 6). 
Nakazaki et al.62 have managed to isolate the (+)-ketone 12 enantiomer.  The (-)-12 enantiomer was 
also successfully isolated by Mueller et al.63  For normal molecules without D3 symmetry one 
would expect that addition of a nucleophile to the carbonyl carbon of the trishomocubane 












These molecules will normally be diastereomers 
if the molecule does not have D3 symmetry  
Figure 7: Alcohol “diastereomers” of the quaternary substituted carbon of trishomocubane 
There are essentially two experimental approaches to the rearrangement of the PCU skeleton to 
trishomocubanone 12. 
The first route (Scheme 6 and Scheme 7) was reported by Dekker et al.64 and the second method 
(Scheme 8) was reported by Kent et al.   The first method starts with the hydroxyketone 30 which is 
converted to an alcohol 31.  The alcohol can then be rearranged as will be demonstrated later.  
Synthesis of the alcohol 31 from the diketone 19 involves protection of the free ketone via ketal 
formation for the purpose of mono-ketone reduction.  Mono protection is achieved by refluxing the 
dione 19 in toluene/benzene in the presence of p-toluenesulfonic acid and 1,2-ethanediol in a Dean 
and Stark apparatus to yield the mono-ketal (pentacyclo-[5.4.0.02,6.03,10.05,9]-undecane-8,11-dione-
mono-ethylene ketal 28).65  Even with excess 1,2-ethanediol only one side of the diketone can be 























Scheme 6: Synthesis of pentacyclo-[5.4.0.02,6.03,10.05,9]-undecane-8-ol (31) 
The mono ketal 28 is then reduced using sodium borohydride (or lithium aluminium hydride) in 
ethanol to yield the hydroxy-ketal 29 (11-hydroxypentacyclo-[5.4.0.02,6.03,10.05,9]-undecane-8-one-
ethylene ketal).29,65  Deprotection of the hydroxy-ketal 29 is achieved by hydrolysis of the ketal in 
10% (v/v) hydrochloric acid to yield the hydroxy-ketone 30.  Reduction of the alcohol using the 
Huang-Minlon method gives the PCU alcohol 31 which has a distinct camphor-like smell.30,64,69
Rearrangement of pentacyclo-[5.4.0. 02,6.03,10.05,9]-undecane-8-ol 31 to pentacyclo-[6.3.0.02,6 
.03,10.05,9]-undecane-4-ol 27 is achieved by refluxing in glacial acetic acid and concentrated 























Scheme 7: Synthesis of pentacyclo-[5.4.0.2,6.03,10.05,9]-undecane-8-one (9) and (D3)-
trishomocuban-4-one (12) 
The trishomocuban-4-acetate (orange oil, 32) is then hydrolysed by stirring in methanol and 
potassium carbonate to yield the white solid trishomocuban-4-ol 27  in good yield (~72%).  An 
overall yield of (~ 45%) trishomocuban-4-ol 27 was obtained relative to 19.  Trishomocubanone 
1223,60 was obtained by refluxing the trishomocuban-4-ol 27 overnight using a Jones oxidation.  An 
overall yield of ~37% trishomocubanone 12, relative to the dione 19 was obtained.   
The second synthetic route (Scheme 8) reported by Kent et al.  for the synthesis of (D3)-trishomo-




















Scheme 8: Kent’s method for the synthesis of trishomocubanone 
The reduction of 19 using sodium borohydride in ethanol readily produced the endo-endo-diol 33 in 
good yield (~75%).  There are various reducing agents that can be used to obtain 33 in good yield 
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e.g. lithium aluminum hydride in THF, 2-propoxide in 2-propanol and NaAl(C2H5)2H2.  Kent et al.  
wrongly reported that all reducing agents favour the endo-endo isomer over the exo-exo isomer.  
LiAlH4 reduction of the dione yields the exo-endo-alcohol as the major product.
66,67   
The rearrangement of the diol 33 into the trishomocubyl system can be effected with acid under 
milder conditions.  The diol 33 can be treated with aqueous HI for 2h at 100°C to give the 
iodotrishomocubyl alcohol 34.23,64,68  Deiodination of 34 is achieved with zinc in acetic acid and 
potassium hydroxide to yield trishomocuban-4-ol 27, which can then be oxidized with CrO3 and 
pyridine to yield the monoketone 12.   
The method by Kent et al.  has three advantages over the method reported by Dekker et al.   It is 
shorter, all reagents required are readily available and preparation appears to be simple.  Although 
the first method reported by Dekker et al.  is longer, it makes use of simple chemistry and produces 
reasonable yields [~43% overall yield for trishomocuban-4-ol 27 and ~37% for trishomocubanone 
12].  The method by Kent gives an overall yield of ~44% trishomocubanone 12 mainly due to the 
poor yield of 34.  Dekker’s method is preferred in our laboratory, mainly because it is well 
established and the shorter method appears to be less consistent in our hands.  
Raasch69 has used computational modelling at the RHF/3-21+G level of theory to enhance the 
understanding of the rearrangement of the PCU diol to trishomocubane.  He showed that the 
intramolecular SN2 rearrangement reaction to fluoro-trishomocubanol 38 can only proceed from 
either the exo-endo PCU diol 35 or the exo-exo PCU diol.  The endo-endo diol 33 can only proceed 
via a SN1 mechanism which is energetically much less preferred.    
Rearrangement of the diol23,64,68 requires refluxing in HI at 100°C for 2h to yield 33 (Scheme 8).  
Hydrofluoric acid was used in the computational investigation by Raasch so as to reduce the size of 
the calculations.  It is apparent that good basis sets for iodine are problematic.70  The computational 
model involves the rearrangement of 35 via the protonation of the 8-exo-hydroxy-11-endo-hydroxy 
PCU 35 with HF to yield 7-exo-fluoro-11-endo-hydroxy-trishomocubane 38 (Scheme 9).  A scan 
calculation was performed to pull the fluorine ion closer to C7 until a maximum was reached.  The 
transition state 37 involves the breaking of the C1-C7 bond of the PCU skeleton and the formation 
of a C1-C8 bond for the cage rearrangement to trishomocubane.  The fluorine ion is facilitating the 
rearrangement where C1 eventually performs an intramolecular SN2 attack on C8, so as to cleave 
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Scheme 9: Proposed mechanism for the exo-endo-PCU diol rearrangement to 7-exo-fluoro-
11-endo-hydroxy-trishomocubane 
The transition state with the exo-endo PCU diol was proven to be ∼2.6 kcal/mol lower than the 
corresponding exo-exo PCU diol transition state.  The fact that the exo-endo diol is kinetically 
preferred to the exo-exo diol implies that the exo-endo diol 35 can be used as the preferred starting 
material.  It also implies that LiAlH4 is perhaps a better choice for the reduction of the dione as exo-
endo-alcohol is the major product,66,67 while reduction with NaBH4 produces the undesired endo-
endo-alcohol as the major product. 
Trishomocubanone 1223,60 was converted to the trishomocubane hydantoin 13 by treatment with 
NaCN, (NH4)2CO3, NH4OH and CH3CH2OH at 100°C (Bucherer-Bergs
71 method - Scheme 11).  
Trishomocubanone 12 has D3 symmetry and has a theoretical advantage over the PCU monoketone 
since only two hydantoin isomers can potentially be formed, compared with four possible hydantoin 
isomers in the case of PCU monoketone 9.   The Strecker or Bucherer-Bergs method can be used to 
obtain the same amino acid (Scheme 11).  However, Munday72 (Scheme 10) found that the 
Bucherer-Bergs reaction of 4-tert-butylcyclohexanone 39 gave predominantly one isomeric 
hydantoin (40, α-isomer), accompanied by only a trace amount of the second isomer (41, β-
isomer).††  Hydrolysis of these hydantoins 40 and 41 furnished the two isomeric amino acids 42 and 
43 (Scheme 10).  While the amino acid of the α-series is the major product of the Bucherer-Bergs 
route, only the amino acid of the β-series can be obtained from the amino nitrile furnished by the 
Strecker route.   
                                                                 
**  “Note that enantiomers have similar properties, as well as identical energies” 






























































Scheme 11: Bucherer-Bergs method for synthesis of amino acid 
The same argument is expected in both trishomocubanone 12 and the PCU monoketone 9.  
Evidence of the successful synthesis of the hydantoin 13 was attributed to the presence of two 
carbonyl absorption peaks at 1772 and 1726 cm-1 and an N-H absorption peak at 3212 cm-1 in the 
IR spectrum.  The 1H NMR spectrum shows two D2O exchangeable peaks.  One at 10.54 ppm 
(imide N3’-H) which was shifted downfield since it is positioned between two electron withdrawing 
carbonyl groups.29,30  A second peak was observed at 7.88 ppm and is due to the amide N1’-H.   
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The 13C NMR spectrum exhibited two carbonyl carbon peaks, at 178 and 152 ppm.  The peak at 152 
ppm was due to the urea carbonyl group (C2’).  The eight methine carbons of the cage are found 
between 39.57 and 55.67 ppm.  The presence of the imide (N3’-H) and the amide (N1’-H) peaks at 
10.54 and 7.88 ppm in 1H NMR proves the successful synthesis of trishomocubane hydantoin.  The 
appreance of two carbonylic peaks at 178 (C4’) and 152 ppm also proved the conversion of a 
ketone carbonyl to a hydantoin ring. 
As a result of the unique D3 symmetry of the trishomocubane cage skeleton, only two enantiomers 










































Figure 8: Trishomocubane hydantoin (13)62,63
Due to the poor yield of amino acid 14 (∼61%) obtained by the sodium hydroxide hydrolysis of the 
hydantoin at 170°C, a further investigation by Raasch et al.  led to the development of a new 






















Scheme 12: Bis-t-Boc method for the synthesis of amino acid 
The two N-H groups of the hydantoin 13 were protected by di-tert-butyl dicarbonate (Boc2O) in the 
presence of a base, triethylamine (Et3N), following Rebek’s method
73 for the hydrolysis of lactams 
and secondary amides.74  Since the carbonyl groups of the t-Boc protected amides and imides are 
more susceptible to nucleophilic attack during hydrolysis, the amino acid 14 is obtained in 
quantitative yield.  The reason for this more facile hydrolysis may be due to release of steric strain 
and the fact that nitrogen is converted into a better leaving group.30,69,73,74  
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A successful synthesis of the bis-t-Boc tris-hydantoin 45 was confirmed by the disappearance of the 
two N-H peaks at 7.88 and 10.56 ppm in the proton NMR spectrum and the existence of four 
carbonyl peaks at 1724, 1751, 1767 and 1801 cm-1 in the infrared spectrum.  The 13C NMR 
spectrum displayed four carbonyl carbon peaks, at 145.79, 149.02, 149.67and 169.58 ppm and were 
identical to the results previously reported by Raasch et al.   The bis-t-Boc hydantoin hydrolysis 
produced > 95% yield of tris-amino acid 14.45,73  The trishomocubane amino acid 14 is isolated at 
pH 6.5 as a zwitterion.29,30,73,74  Due to the poor solubility of the cage amino acid in organic 
solvents [even in DMSO(d6)], only two analytical tools were used to characterize the underivatised 
amino acid 14.  The first test (tool) is the Ninhydrin test (Kaiser test)75 which gives a violet-blue 
















46 47 48 49
 
Scheme 13: Reaction of an amino acid (20) with ninhydrin 
The second analytical tool was infrared (IR) spectroscopy.  Evidence for the successful synthesis of 
the amino acid was the appearance of a broad absorption peak for the carboxylic acid -OH at 3436 
cm-1, and a sharp absorption peak at 3198 cm-1 for the -NH2 group.  A carbonyl absorption peak at 
1623 cm-1 is also characteristic of zwitterion amino acids (Scheme 3)76.  The NMR characterisation 








Figure 9: Fmoc-trishomocubane amino acid 
The protected amino acid 50 is not only useful for the characterisation of the tris-amino acid but it is 
also useful in solid phase peptide synthesis (SPPS) for the controlled coupling of 14 with other 
residues.  Evidence for the successful synthesis of 50 was confirmed by infrared spectroscopy; a 
broad -OH absorption peak was observed at 3417 cm-1, a sharp -NH absorption peak at 3358 cm-1 
and carbonyl peaks at 1744 and 1711 cm-1.  The NMR data obtained were identical to those 
  17
reported by Raasch et al.   In the 1H NMR spectrum of 50 the presence of four peaks from 1.47-3.40 
ppm represents the four cage methine protons (-CH) and the peaks between 1-1.43 ppm represents 
the four methylene groups (-CH2).
30,77, ,78 79  The multiplet between 7.00 and 8.00 ppm represents 
the aromatic protons of the Fmoc group.  A broad peak between 10.0 and 12.5 ppm is typical of a 
carboxylic acid -OH.  Note that the –OH peak between 10 and 12.5 ppm is only visible when 
DMSO(d6) is used as a solvent but not when deuterated chloroform is used. 
Two carbonyl peaks were present at 174 ppm and 155 ppm in the 13C NMR spectrum.  The 
methylene carbon peaks were observed at 31.7-32.7 ppm, the methine carbon peaks at 40.0-80.0 
ppm, and the aromatic carbons were registered between 120.0-142.0 ppm.  Note that the integration 
values of the aromatic protons are a bit higher than expected due to an overlap with the solvent 
peak.  Further evidence for the successful synthesis of 50 was a negative ninhydrin test.   In the 
mass spectrum the observation of a molecular ion [M+H]+ = 428 m/z peak was taken as further 




Peptide synthesis is an art, the practice of which nowadays requires its own book.80  Peptides are 
compounds consisting of two or more amino acids which are linked together by amide bonds 
(peptide bonds).  The peptide bond is of central importance in biochemistry and protein 
chemistry,81, ,82 83 as it provides a linkage between amino acids in peptides and proteins.  Peptides 
which contain 2 to 15 residues are called oligopeptides and those which contain more than 10 
residues are called polypeptides/proteins.  Oligopeptides have commonly been used as ligands 
and/or in drugs with high affinity and specificity for particular receptor sites.84  Non-proteinogenic 
amino acids are vital in the future of peptide-related drugs.29,46,85  It is widely believed that the 
incorporation of conformationally constrained amino acids is a good strategy for the design and 
development of selective drugs.  Peptides play an important role in modern drug design and 
synthesis.  Analysts have estimated the peptide market to be worth 12 billion US dollars and many 
people now consider peptides the drugs of the future.  The term “peptide” was first proposed by 
Emil Fischer in 1901, and the first peptide, synthesised in 1901, was the dipeptide Gly-Gly 
(glycine-glycine) made by treating dioxopiperazine with mineral acid.  The term peptide is similar 
to “peptones”, which are products of protein degradation by pepsin.  Peptides have very attractive 
advantages as they can be made highly specific and their potency can be increased, by simple amino 
acid substitution.  Synthetic peptide chemistry reached its climax after the synthesis of the 
neurohypophyseal hormone oxytocin 51 in 1953 by V. du Vigneaud.42,48,86
Cys Try Ile Gln Asn Cys Pro Leu Gly NH2
S S
51  
Figure 10: Oxytocin 
This hormone has many functions but only few of them will be presented in this report.  It is 
involved in the facilitation of birth and breastfeeding as well as in bond formation between people 
(trust).  The hormone 51 is sometimes called the hormone of love, since it facilitates the emotional 
bond between a mother and child.87   
In general a peptide bond is formed by nucleophilic attack of the N-atom of the second component 
on the carbonyl C-atom of the first.  Crystallographic studies have shown that the amide bond (-CO-
NH-) is shorter than the normal C-N single bond, due to the mesomeric nature of the amide bond 
which restricts the free rotation about the C-N bond.88  The amide group is “flat” with the nitrogen 
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sp2 hybridized.  The hydrogen in N-H is normally in a trans-position with respect to the carbonyl 
oxygen 52 as this minimizes the steric hindrance between the R-groups of the two adjacent amino 






















Figure 11: Delocalization in peptide backbone 
The backbone conformation of a peptide can be described by three torsion angles, ω (omega), ψ 
(psi) and φ (phi) illustrated in (Figure 12, 53).  The partial double bond character of the amide bond 
ensures that the C, O, N and H atoms of the amide bond lie in a plane (see 52 in Figure 11 above), 













Figure 12: Rotation of the peptide backbone defining the ω, ψ and φ torsional angles 
Peptide synthesis is sub-divided into two types: the classical (solution) method and the solid phase 
peptide synthesis (SPPS) method.  The solution method essentially disappeared due to the 
difficulties associated with solubility and purification of the peptide as the number of amino acids 
residues increases.90  To overcome these difficulties a new SPPS approach to peptide synthesis was 
initiated by R.B. Merrifield in 1963.  Solid phase synthesis is based on the attachment of the 
protected amino acid of the chain to a linker, which is covalently bonded to a solid polymer (resin).  
Successive protected amino acids are added one at a time in a stepwise manner until the desired 
sequence is accomplished.  In many textbooks Nα-protection (temporary protection) is achieved by 
the t-Boc-group; however in this dissertation the Fmoc-group was utilized for Nα-protection 
allowing acid activation through conversion of the acid function to an acid fluoride if required.   
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A t-Boc chemistry uses trifloroacetic acid (TFA) for primary deprotection of the t-Boc-group and 
TFA can also potentially alter sensitive peptide bonds.  In Fmoc chemistry primary deprotection is 
achieved by a mild base such as piperidine.  The advantage with Fmoc synthesis is that TFA is only 
used for the final cleavage of the crude peptide and deprotection of side chains such as the tert-butyl 
protecting group in the case of side chain amino acids (e.g. aspartic acid).91  Fmoc based SPPS can 
be summarised into the following sections: solid support (resin), linker, attachment of the first 
residue, protecting groups, Fmoc deprotection, coupling reagents, monitoring, cleavage and 
removal of the protecting groups, peptide evaluation and peptide modification.  The mechanisms for 















































Scheme 14:  Deprotection of t-Boc-amino acid with trifluoroacetic acid (TFA) and Fmoc-
amino acid with piperidine 
Essential to SPPS is that the polymer support (resin) must not be soluble in any of the solvents used, 
and must swell so as to facilitate the reaction.  The advantage of this approach over the classical 
method is that, when the growing peptide chain is firmly attached to a completely insoluble support, 
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 it is easy to filter off the solid resin and to wash away‡‡ free reagents and by-products.90,99  
Purification of the peptide is not done by recrystallisation but by ensuring 100% coupling (negative 
ninhydrin test) and removal of the impurities, which simplifies the manipulations and shortens the 
time required for the synthesis of the peptides. 
The development of the handles§§ (linker) for the SPPS method has resulted in the successful 
synthesis of many useful peptides like Human Gastrin-I.92  The linker must be soluble but not 
cleaved from the resin by any solvent used [i.e. N,N-dimethylformamide (DMF) and isopropanol] 
in order to allow added residues to couple to it.§§  However it should be easily cleaved at the final 
deprotection of the crude peptide without destroying the desired product.69,91,103  Alberico et al.  
have developed a linker (5-(4-(9-fluorenylmethyloxycarbonyl)aminomethyl-3,5-dimethoxy-
phenoxy)-valeric acid, PAL) 63 which works well with the p-methylbenzhydrylamine resin 
(MBHA) 64 to produce peptide amides.  Progress since Fischer’s first dipeptide in 1901, especially 
the development of SPPS in the 1970s enables us to synthesise numerous complex peptides in the 
laboratory.   
Most studies in Kruger’s group at UKZN make use of p-[(R,S)-α−[1−(9Η−fluoren-9-yl)methoxy-
formamido]-2,4-dimethyl-benzyl]-phenoxyacetic acid (Fmoc-AM linker) 65 and the MBHA resin 















65 Fmoc-AM linker  
Figure 13: Linkers and resin (PAL, MBHA and Fmoc-AM linker) 
                                                                 
‡‡ A typical washing procedure is: 3x DMF, 3 x Isopropanol and 3x DMF 
§§  “Handles (linkers) are bifunctional spacers which serve to attach the initial residue to the polymeric support in two discrete steps.  
One end of the linker incorporates features of a smoothly cleavable protecting group, and the other end allows facile coupling to a 
previously functionalized support.” 
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The coupling of the FmocAM linker 65 to the resin was achieved with the help of in situ coupling 
reagents like 1-Hydroxybenzatriazole (HOBt) 66, N,N-Diisopropylcarbodiimide (DIPCDI) 67 and 
2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) 68 (see Figure 


























Figure 14: In situ coupling reagents (HOBt, DIPCDI, and HBTU) 
HOBt was used as a catalyst in the reaction while N,N-Diisopropyldicarbodiimide (DIPCDI) acts as 
a dehydration agent, producing a soluble urea which is washed away‡‡ with                                N,N-
Dimethylformamide (DMF) and isopropanol.  HOBt inhibits the formation of oxazolone (cyclic 
lactone) by forming an ester with the carboxylic acid group and also suppresses the racemization of 
amino acids.  Other in situ coupling reagents like O-(7-Azabenzotriazol-1-yl)-1,1,3,3-
tetramethyluronium-hexafluoro-phosphate (HATU) can also be used.   
N,N-Dicyclohexylcarbodiimide (DCC) is not used in SPPS since it forms an insoluble urea which 
can block the polystyrene filter.  The successful attachment of the linker is monitored with the 
ninhydrin test.   The ninhydrin test is negative when the solution is red-brown and positive if the 
solution turns dark blue or purple.  The TNBS (2,4,6-Trinitrobenzenesulfonic acid) test94 can be 
used as an alternative, since some deprotected amino groups do not show the required violet-blue 
colour with the ninhydrin test.95  The TBNS test96 is positive when resin beads turn yellow or red 
within one minute and negative when the beads remain colorless.94,95  As the synthesis of the 
peptides with SPPS required many steps, it was decided to first synthesize short peptides to gain 





















Figure 15: Ala-Ala-Ala (tri-peptide) 
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The resin 64 and a linker 65 were coupled in the presence of in situ coupling reagents 66 and 67 in 
DMF.  The successful attachments were verified by a negative ninhydrin test.  The Fmoc group was 
removed by 20% piperidine in DMF and a positive ninhydrin test (Scheme 13) was observed.  This 
was followed by the successive addition of the three alanines in the presence of 66 and 67.  The 
peptide 69 was washed*** with dichloromethane, methanol and diethyl ether, followed by drying in 
a vacuum dessicator.  Final cleavage was achieved using 95% trifluoroacetic acid, 2.5% 
triisopropylsilane and 2.5% water.31,69  Triisopropylsilane was added as a carbocation scavenger.  
The peptide was filtered and cold diethyl ether was added until the precipitate of the crude peptide 
occurred.  The peptide was centrifuged and washed several times with diethyl ether under nitrogen 
to remove the linker.  The characterization of the tripeptide is discussed below in the results and 
discussion section.  
Attempts to incorporate sterically hindered amino acids into peptides using classical (solution) 
methods have been made and have led to highly useful analogues of many bioactive peptides.97  
The effect of hydrophobic side-chains upon helix stability have been tested by the incorporation of 
non-natural hydrophobic amino acids such as α-aminobutyric acid (Abu, 70), norvaline (Nva, 71), 










R= CH2CH2CH2CH3  
Figure 16: Non-natural hydrophobic amino acids (Abu, Nva and Nle) 
The most frequently used hydrophobic helix-stabilising amino acid is α-aminoisobutyric acid (Aib, 
73) which occurs in microbial peptides, such as alamethicin.  Using crystallographic studies, Aib 
based peptides revealed an overwhelming preference for right or left-handed helices (310 and α).    
The incorporation of non-natural amino acids such as Aib 73, adamantinine 24, dipropylglycine 
(Dpg, 74) and dibutylgylcine (Dbg, 75) into peptides enhanced the scope of peptide design and 
protein engineering by imposing local restrictions on polypeptide chain stereochemistry, thus 
enhancing the stability of specific regions of the secondary structure like α-helix/β-sheets.99  
Further advantages may include:57,99
• enhanced binding to a molecular target, 
                                                                 
*** A typical washing procedure is provided in the experimental section.   
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• improved oral bioavailability100 and longer persistence in circulation in the case of biologically 





73 R = CH3
74 R = CH2CH2CH3





Figure 17: Non-natural amino acids (Aib, Dpg, Dbg and adamantinine) 
Computational studies predicted promising behaviour of cage amino acids when incorporated into 
peptides and is leading our synthetic approach at this stage (see the introduction in Chapter 2).  The 
challenge is to verify the computational prediction35,36,37,38,40 through a synthetic approach.  This 
prompted an intensive synthetic effort at UKZN to incorporate the cage moieties such as 4, 5 and 7 
into peptides.  It is also hoped that the cage amino acids would also improve the transportation of 





Figure 18: Cage††† compounds (PCU, 4, trishomocubane, 5 and camphor, 7) 
There have been various attempts in the research group at UKZN to incorporate 4 and 5 into 
oligopeptides.  Govender attempted to incorporate the trishomocubane amino acid 14 into a 
dipeptide using an achiral glycine, but failed to purify the product using high performance liquid 
chromatography (HPLC).  Raasch has attempted to make a tri-peptide with 14 using achiral glycine 
in the second (i+1) position and alanine in the third (i+2) position but could not purify it using 
HPLC.  The use of glycine in the second position is suspected of assisting the formation of a six 
membered ring Schiff base (folding of peptide-Scheme 15) due to the lack of steric hindrance in 
glycine.  It was subsequently decided to use alanine rather than glycine.  
Bissety et al.35,36,37,38,39,40 used force field and ab initio calculations to show that the incorporation 
of a cage 4 moiety into peptides induces an α-helix (i, i+4) mostly 310-helix (i, i+3) due to the steric 
interaction of the cage.  It was also demonstrated35,36,37,38 that the PCU amino acid is a better β-turn 
                                                                 
††† Camphor is strickly speaking not a classical cage compound, but is structurally related to the PCU skeleton. 
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inducer than Aib and could be compared to proline.  Theoretical [Amber (parm94) and ab initio, 
rhf/6-31G(d)] results have predicted that the trishomocubane amino acid 14 containing peptides 
would potentially favour four low energy conformers, namely the C7ax, C7eq, 310 and αL helical 
conformations.37,39  
There are several reasons for using alanine (Ala) instead of glycine (Gly) and other amino acids:  
• Ala is a strongly helix stabilising residue.  It is believed that the methyl side-chain reduces the 
conformational freedom of Ala, forcing it to adopt a helical conformation. 
• Based on electron spin resonance (ESR) studies, Ala based peptides form a 310-helix (i, i+3) 
which is similar to β-turns (i, i+3) rather than an α-helix.89, ,  101 102
• The methyl side-chain of Ala can inhibit the folding of the peptide to form a Schiff base 
(Scheme 15) due to the steric hindrance imposed by the methyl side chain.  
• In contrast to other amino acids, the methyl group is small and steric clashes with other side 
chains are not too large to prevent effective coupling.  In addition there is no loss of side-chain 
entropy on helix formation. 
Mdluli103 has attempted to use alanine (i+1) in the Ala-Ala-Ala-PCU, where PCU is the 
pentacyclo-undecane amino acid 11, to prove that the methyl side chain of Ala prevents the peptide 




Figure 19: PCU amino acid 
The fact that a positive ninhydrin test was observed by Mdluli after the incorporation of the cage 
amino acid 11, implies that alanine in the second (i+1) position had prevented the formation of a 
Schiff base. 
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Scheme 15: Formation of a Schiff base 
Purification of the peptide using preparative HPLC was found to be difficult due to the small 
amount of peptide obtained.  Further characterisation of the peptide by crystallographic studies, to 
prove the helical (310 and α) nature of alanine rich peptides and the effect of the hydrophobic cage 
(PCU) in α-helix to 310-helix and β-turns were not achieved.   
Results obtained from using the SPPS method are discussed below.  The successful synthesis of the 
tri-peptide 69 (Ala-Ala-Ala) was verified by the presence of three carbonyl peaks in the IR 
spectrum at 1554, 1627 and 1677 cm-1.  The carbonyl peak at 1553 cm-1 is at low frequency since it 
is adjacent to an –NH2 group.  The appearance of two sharp peaks at 3406 and 3298 cm-1 (-NH 
stretching) also assisted in further verifying the successful synthesis of 69.  The 1H NMR was 
difficult to interpret since the peptide was not dry enough.  The peptide was recovered and dried 
again under high vacuum, but somehow it appears as if perhaps water of crystallization was still 
present.  In the 13C NMR spectrum three carbonyl peaks at 168, 172 and 175 ppm confirmed the 
successful synthesis of 69.  Three methyl peaks at 15.08, 15.41, and 15.98 ppm were also observed.  
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The purity (40%) of the peptide 69 was confirmed by HPLC analysis.‡‡‡  A full discussion of the 
HPLC conditions is given in the experimental section (Chapter 6). 
At this stage the addition of tris-amino acid fluoride 78 to the tri-peptide 69 was attempted due to 
previously unsuccessful attempts to couple the Fmoc-tris-amino acid 50.   The coupling with 
halogenated Fmoc amino acid 78 was considered to be essential as acid halides are more reactive 
than carboxylic acids and to ensure successful coupling of the sterically hindered α,α-disubstituted 
tris-amino acid.69, ,104 105  It was therefore essential to first synthesize the acid halide 78 from Fmoc-
tris–amino acid 50.  The conversion is obtained through treatment of 50 with cyanuric fluoride and 
dry pyridine in dry methylene chloride.30,45,69  Note that the detailed synthesis of 78 is discussed in 
the experimental section.  Coupling of the Fmoc-tris-amino acid fluoride 78 was attempted to the 
tri-peptide 69 (still attached to the resin) along with pyridine, as an HF scavenger, to produce the 
tetra-peptide (Ala-Ala-Ala-tris, 79).  Deprotection of the Nα-protecting groups (Fmoc group) was 
achieved by treatment of the peptide with a 20% piperidine in DMF for 30 minutes (Scheme 14).  A 
positive ninhydrin test (Scheme 13) was obtained after deprotection confirming the successful 
coupling of 78 to the peptide.  The peptide 79 was stripped from the resin and the 13C NMR analysis 
further proved the successful deprotection of the Fmoc group.  This was confirmed by the 
disappearance of the Fmoc multiplets between 120 - 140 ppm.  The peptide was then washed with 
DMF and isopropanol.‡‡  It was prepared for cleavage by washing with dichloromethane, methanol 
and diethyl ether and dried under vacuum overnight.   Final cleavage was achieved using a solution 
of 95% trifluoroacetic acid, 2.5% triisopropylsilane and 2.5% water.31,69  The peptide was filtered 
and cold diethyl ether was added until the precipitate of the crude peptide occurred.  The peptide 
was centrifuged and washed several times with diethyl ether under nitrogen as to ensure that the 


































Figure 20: Ala-Ala-Ala-tris (79) and Fmoc trishomocubane (tris) amino acid fluoride (78) 
The peptide had some impurities which were confirmed by HPLC.  The low yield of peptide 79 
implies that the attachment of the cage amino acid to a peptide is problematic and the extension of 
reaction times as well as excess cage amino acid are required.  The purity of peptide 79 was 
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‡‡‡ C18 Reverse phase column, 80% acetonitrile in water, a flow rate of 1ml/min and ran for 60 minutes in isocratic solution. 
measured by HPLC analysis, which gave four peaks at 3.53, 4.69, 5.73 and 14.71 minutes.  The 
single peak at 3.53 min corresponded to the unreacted tri-peptide 69 while the peak at 14.71 min is 
suspected to correspond to the hydrophobic/ less polar tetra-peptide 79.  It is expected that 
hydrophobic compounds elute later than hydrophilic compounds since they have a higher affinity 
for a C18 reverse phase column.  The peptide 79 is supposed to be a diasteriomeric mixture as the 
trishomocubane amino acid 14 is synthesised as a racemate.  At this stage it is not yet possible to 
say if one of the other HPLC peaks is due to the other diastereomer.   
The successful synthesis of the tetra-peptide 79 was verified by the presence of four carbonyl peaks 
in the IR spectrum at 1548, 1624, 1677 and  1756 cm-1.  The carbonyl peak at 1548 cm-1 is at low 
frequency since it is adjacent to an -NH2 group.  The appearance of two sharp peaks at 3394 and 
3298 cm-1 due to -NH stretching also assisted in confirming the synthesis of 79.  1H NMR was 
difficult to interpret since it again appeared as if water was trapped in the crystals.  The appearance 
of five -NH peaks between 6.90-9.00 ppm confirmed the successful synthesis of 79.  In the 13C 
NMR spectrum four quaternary peaks at 159, 171, 172 and 174 ppm were also observed.   
Further work was undertaken, attempting to incorporate 78 in the centre of the hepta-peptide 80.  










































Figure 21: Ala-Ala-Ala-14-Ala-Ala-Ala (hepta-peptide) 
The synthesis of peptide 80 was performed in one attempt.  Excess cage amino acid fluoride was 
used for the coupling of the trishomocubane amino acid, as well as extended reaction times. 
According to the HPLC results the purity of 80 was low in the crude peptide mixture.  Two peaks 
eluting at 2.76 min and 32.59 minutes were observed in the HPLC chromatogram.  The peak at 2.76 
min is suspected to correspond to the unreacted tri-peptide 69 and the peak at 32.59 min was due to 
the desired product 80.  The time required to elute 80 is different from the time to elute 79, this may 
due to the different size of the two peptides.  Therefore 80 has a higher affinity for the C18 reverse 
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phase column.§§§  It was clear that the polarity of the solvent could be changed from 80% 
acetonitrile in water so as to minimize the time required to elute 80, however due to time constraints 
only qualitative analysis of the peptide was undertaken. 
The successful synthesis of 80 was also verified by IR spectroscopy which showed seven carbonyl 
peaks at 1544, 1558, 1622, 1634 (as a shoulder), 1653 (as a shoulder), 1678 and 1731cm-1.  The 
pure product may in practice only exhibit five carbonyl peaks in the IR spectrum, since the carbonyl 
groups in the amino acid segments i+2 and i+5 may overlap.  The presence of two broad peaks at 
3295 and 3400 cm-1 for –NH stretching also confirmed successful synthesis of 80.  The compound 
80 had some impurities which were observed in the 1H NMR spectrum.  The appearance of seven 
peaks between 6.90-9.00 ppm (-NH peaks) also supported the evidence for the successful synthesis 
of 80.  The 13C NMR (poor quality) showed seven quaternary peaks at 170, 171, 171, 171, 174, 174 
ppm and the peak shifted upfield to 155.36 ppm.  The peak at 155.36 could be an amide peak of the 
other terminal.  The molecular ion peak of [M+H]+ = 631 m/z in the mass spectrum further 
confirmed successful synthesis of 80.  Fragmentation in the mass spectrum corresponded well to the 
breaking of the peptide chain.  For example a peak at m/z = 560 correspond to the [M-Ala]+ and a 
peak at m/z = 489 correspond to the [M-(Ala-Ala)]+.  However the other peaks become more 
complex in the spectrum.  A schematic summary of the peptide synthesis is depicted below 
(Scheme 16). 
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Scheme 16: Summary for the synthesis of Ala-Ala-Ala (69) 
A similar procedure was used for the synthesis of 79 and 80.  Schiff base formation (see Scheme 
15) was prevented by using alanine in the second (i+1) position of both reported peptides.  It was 
found difficult to do structural elucidation by NMR due to the impurities observed in 1H NMR 
spectra and the wetness of the peptides.  It is necessary to dry the peptide using a lypholizer for 
NMR studies since a broad water peak appeared in all NMR spectra.  Purification of the peptides by 
Preparative HPLC would require larger quantities of the peptides. 
As part of collaboration between the research group at UKZN and the Uppsala University106 in 
Sweden, a sample of the amino acid 14 was sent to them.  The results obtained in this investigation 
(UKZN) was communicated to the Uppsala group.  The hepta-peptide was successfully synthesized 
and separated by a former student from the UKZN research group, Dr T. Govender, now working 
for the Uppsala group.  Since the trishomocubane amino acid 14 has D3 symmetry and is 
synthesized as a racemate, two products were separated as Ala-Ala-Ala-(R/S)-14-Ala-Ala-Ala 
peptides.  The unique symmetry of the cage structures ensures that only two enantiomers are 
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formed due to the substitution at quaternary carbon see Figure 7, instead of four diastereomers.  The 
peptide was synthesized using the normal SPPS method**** with a different resin than the one used 
at UKZN.  The two diastereomers were separated by HPLC.††††  Crystals of both peptides were 
grown and the diastereomers were analysed using a single crystal X-ray crystallographic 
analysis.107  The X-ray results obtained for both enantiomers are presented below.  It was some 
what surprising that both diasteromers produce essentially the same peptide backbone (see Figure 
23).  Only one of the enantiomers was investigated computationally so far and one would have 
expected a bigger difference between the peptide backbones of the two diastereomeric peptides. 
It is important to note the two diastereomers were separated by approximately 4 minutes in the 
HPLC spectrum.††††   
 
                                                                 
**** Sieber amide resin, Fmoc amino acid (1.5 eq), HATU (3 eq), DIPEA (6 eq), 90 min, TNBS test. Cleavage 95:2.5:2.5 
TFA:TIS:water for 1 hour. 




a = 10.7690(5), b = 12.4820(4), c = 26.6490(10) Å
R-factor = 0.0522
Cage2, Orthorhombic, P212121
a = 11.0100(3), b = 12.3470 (3), c = 26.7020(4) Å
R-factor = 0.0435  
Figure 22: X-ray structure of Cage 1& 2 (Ala-Ala-Ala-tris-Ala-Ala-ala) 
 
 
Figure 23: Overlay of the two X-ray structures  
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Chapter 4 
Computational chemistry studies and theory 
As indicated in the introduction (Chapter 1), a simplified computational model for the 
esterification of acids was required to enable a better understanding of the mechanism of 
esterification.  Once that is achieved, the model could be extended to investigate more complex 
systems such as the cage amino acids 11 and 14.  Kruger108 proposed a unique cyclic transition 
state for the acetylation of amines and alcohols with acetic anhydride.  The purpose of this 
computational study was to extend the model to include acetylation of alcohols with acid chlorides 
and carboxylic acids. 
The model developed by Kruger  was based on ab initio calculations.  A mechanism via a six 
membered ring cyclic transition state (83) between alcohols, amines and the incoming acetic 
anhydride was postulated (Scheme 17).  This project was then extended to include the 
regioselective acetylation of a pentacyclo-[5.4.0.02,6.03,10.05,9]-undecane lactam (δ-lactam, 96) and 
various hydantoins (5-methylhydantoin 100, 5,5-dimethylhydantoin 101, and pentacyclo-
[5.4.0.02,6.03,10.05,9]-undecane hydantoin, 102) with acetic anhydride.109,110
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Scheme 17: Cyclic mechanism vs acyclic mechanism  
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Esterification reactions are performed daily in many research laboratories throughout the world.  In 
C→N peptide synthesis methods, esterification (protection of acid side chains) has been used for 
the protection of carboxylic acid groups of amino acids, since none of the amino acid forms (i.e. 
cationic, zwitterionic, and anionic, Scheme 3) which are present in solution at any pH are viable 
candidates for peptide bond formation.111,112  This is due to the presence of the protonated amino or 
the anionic carboxylate group, and it is only by esterification that the neutral form of the amino 
function dominates in solution at neutral pH.113  Esterification enhances peptide bond formation 
most likely by transforming amino acids to neutral species, in which nucleophilic attack of the 
amino nitrogen on an electrophilic carbonyl carbon is more feasible than for zwitterionic or anionic 
amino acids.114  The N→C peptide synthesis, which required protection of the acid function via 
esterification, has disappeared since esters are good leaving groups which results in the formation of 
diketopiperazines (cyclic dipeptides).  
Side chain carboxylic acid group protections are also performed in SPPS by alcohols such as 
adamantan-1-ol, adamantan-2-ol and by isobutene (2-methyl-1-propene).   Amino acids with side 
chains such as aspartic acid (Asp) and glutamic acid (Glu) are protected by alcohols for C→N 
synthesis.115  The common side reactions that occurs when coupling unprotected Asp is 
intramolecular cyclisation to form succinimide and β-aspartyl peptides.116,117  Glutamic acid also 
undergoes cyclization to form γ-glutamyl peptides.   In these amino acids (Asp, Glu) side chains 
need to be protected since the desired peptide may be not achieved if they are unprotected.  In Fmoc 
chemistry the side chain protecting groups which are used must be stable in basic conditions for 
example adamantan-1-ol and isobutene.115, ,118 119  So, apart from an interest in understanding the 
mechanism of esterification to ultimately explain the difference in reactivity between the acid 








Figure 24: PCU(11) and trishomocubane amino acids (14) 
 
  35
There are various important questions that need to be answered with regards to the understanding of 
the esterification mechanism of alcohols with acids and acid chlorides: 
 Can a six membered ring transition state be used as computational model for these 
reactions? 
 A four membered ring transition state should be considered.  How will the activation energy 
of a four membered ring compared with a six membered ring transition state (if possible)? 
 Does bond formation occur in a concerted or stepwise mechanism? 
 What is the molecular and electronic structure of each transition state? 
 What are the associated activation energies? 
 What are the effects of entropy on the mechanism? 
 What is the nature of solvent effects on the mechanism? 
Computational simulations were undertaken with acetic acid, acetyl chloride, and methanol so as to 
understand the mechanisms and to investigate a similar six membered ring transition state.  The 
field of computational chemistry is a field that can be said to be both old and young.120  The fact 
that its foundation was laid with the development of quantum mechanics in the twentieth century 
makes it old.  It is young since there is no technology in human history that develops at a pace like 
digital computers.   Computational chemistry does not only cover the quantum mechanics but it also 
covers molecular mechanics, minimizations, simulations, conformational analysis, and other 
computer-based methods for the understanding and the prediction of the behaviour of molecular 
systems.121  Theoretical chemistry and computational simulations have gained much attention as 
powerful computers and user-friendly software packages have become more widely available.122
Computational chemistry provides solutions that relate the laboratory data (e.g., IR, UV/vis, NMR 
spectra, heat capacities, reaction cross-sections) to molecular properties (e.g., geometries, bond 
energies, activation energies) under investigation.   Another important application is that it can 
calculate the shapes of various orbitals (e.g., HOMO and LUMO) of the molecule.  All the 
simulations of chemical structures carried out in computational chemistry use mathematical 
methods and the fundamental laws of physics.    
Computational chemistry has become a powerful tool in many research fields including the 
pharmaceutical industry and the academic chemistry environment.   It can provide important 
information about the kinetic and thermodynamic control of a reaction, like the energy barriers 
relative to reactants between intermediates and products.123  Thermodynamic and kinetic data, such 
as the energies of starting materials, intermediates, transition states and products, are difficult to 
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obtain by experimental techniques.114,124  Computational chemistry offers a unique opportunity to 
enhance our understanding of basic chemistry.  For example when there are two competing reaction 
pathways from the same starting material, one can use computational modelling to picture the 
kinetics (activation energy) of the respective transition states‡‡‡‡ leading to the different products.  
The products can be optimized and the relative stabilities provide a measure of the thermodynamic 
stability of the products.  For example, a reaction was modelled where a single enantiomer of an 
alkene (having a stereogenic centre which was directly attached to the prochiral double bond) was 
experimentally observed to produce two competing products when it was treated with an achiral 

















Scheme 18: Epoxidation of a prochiral (93) alkene  
The rate of reaction was dependant upon the energy barriers (activation energies) of the transition 
states between these two competing reactions.  The energy profile of the computational model 
showed that the epoxidation to 95 was both kinetically and thermodynamically favoured.  This may 
seem easier than it really is, since it requires a lot of organic chemistry knowledge and experience to 
visualize the nature/geometry of the transition state connecting the alkene with the epoxide.  
Fortunately there are strategies available to assist the novice computational chemist to find difficult 
transition states.  Some of these strategies will be discussed below.  
Modelling of chemical structures is based on two categories which are the backbone of 
computational chemistry viz: Molecular Mechanics (MM) or Force Field methods and Electronic 
Structure methods.  They both perform the same basic types of calculations among others, the 
following are basic examples:  
 Computing the energy of a particular molecular structure.  
 Performing geometry optimization, which locates the lowest energy molecular structure. 
                                                                 
‡‡‡‡ A transition state is a stage that link reactants to products in a reaction.  A transition state is a maximum on the energy surface 
of the system.
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 Computing the vibrational frequencies of molecules resulting from interatomic motion 
within the molecule.  
The two methods can differ in that the Molecular Mechanics methods perform computations based 
on the interaction among the nuclei, while the Electronic Structure methods consider electronic 
effects (electron density) for its calculations. 
Molecular mechanics performs simulations using laws of classical physics e.g. Newton’s mechanics 
(eqn: 1) to predict the structures and properties of molecules.123, ,125 126
 F = ma (1) 
This equation forms the basis of Hook’s law, which is again the closer basis of MM.  The molecule 
is seen as a collection of hard spheres (the nuclei) connected by flexible springs (the chemical 
bonds).  Electrons are not taken into account explicitly and, as a result, thermochemical properties 
such as the heat of formation, ∆Hfo, has not been easly calculated  until the period of 1976-1977, 
when standard powerful methods for studying molecular structures and related properties were 
developed.127,128  Molecular mechanics is a fast method that uses minimal computer resources.  
They are useful tools in the study of very large molecules like proteins and nucleic acids.  The 
foundation of molecular mechanics methods is due to the observation that molecules tend to be 
composed of units which have structural similarities in various molecules.  For example, all C-H 
bond lengths are roughly constant in all molecules, between 1.06 and 1.10 Å.  The C-H stretch 
vibrations are also similar, between 2900 and 3330cm-1, which implies that the C-H force constants 
are also similar.  
Molecular mechanics methods are available in many computer programs including MM3,128,129 
HyperChem,130 and Alchemy.131  Each of these programmes is characterised by its particular force 
fields.  The common element of all MM programmes is that the calculation of energy is related to 
atomic characteristics by force constants via an equation.  
Electronic structure methods use the laws of quantum mechanics rather than classical mechanics 
since electrons are very light particles (compared to nuclei) that cannot be described quantitatively 
by classical mechanics.   Quantum mechanics states that the energy and related properties of a 
molecule may be obtained by solving the Schrödinger equation (eqn: 2)  
 Ηψ = Εψ (2) 
Where, H is the Hamiltonian operator: 
  E is the energy. 
  ψ is the wave function. 
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There are two major classes of electronic structure methods that are used for modelling viz: 
• Semi-empirical methods such as AM1, MINDO/3 and PM3 which are implemented in 
programmes like MOPAC132, AMPAC , HyperChem  and Gaussian133.  These methods use 
parameters derived from experimental data or high level ab initio results to approximate the 
solution to the Schrodinger equation. 
• Ab initio§§§§ methods use no experimental parameters in their computations and are also 
implemented in programmes like GAMESS,134 Gaussian  and Jaguar.135  Its mathematical 
algorithms are based solely on the laws of quantum mechanics and on the values of small 
physical constants such as the speed of light, the mass & charge of electrons and Planck’s 
constant. 
Examples of ab initio methods are Hartree-Fock (HF) theory, second order Møller-Plesset (MP2) 
136 and Coupled Cluster theory137,138.  Ab initio methods compute solutions to the Schrödinger 
equation using a series of rigorous mathematical approximations.  The Born-Oppenheimer 
approximation is an important approximation which enables electronic and nuclear motions to be 
separated.  In the Born-Oppenheimer approximation the change in electronic motion is a function of 
the nuclear shift, so that a small change in nuclear position can result in a change in electronic 
position and also a change in the energy of the molecule.   Ab initio methods do not solve the 
Schrödinger equation exactly but an algorithm is used that can lead to a reasonable approximation 
to the solution of the Schrödinger equation.  An exact solution to the Schrödinger equation can be 
obtained for small molecules like H2.   
The algorithm makes use of a basis set, which is a mathematical description of the orbitals involved.  
A more elaborate discussion on the nature of basis sets will be provided below.  One can use 
primitive basis sets, which use severe approximations, or one can use better basis sets that 
represents a more realistic description of the orbitals.  It is important to note that a method (semi-
empirical or an ab initio method) and a basis set which are adequate for one application may be 
inadequate for another.  The disadvantages of ab initio methods relative to other methods are with 
respect to computational resources and speed.139
Density functional theory (DFT) method is another electronic structure method which has gained 
wide application in the field of computational chemistry.  It remains controversial as to whether 
DFT is an ab initio method or not, but it uses the same CPU resources as Hartree Fock (HF) theory, 
the least expensive ab initio method according to computer time.  DFT methods are based on the 
theory by Hohenberg and Kohn140,141 in which they demonstrated that the ground state energy of 
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any molecule can be described in terms of the total electron density, which means that each 
molecule has a unique functional form which exactly determines the ground state energy and 
electron density of the molecule. 
DFT approximates the effect of electron correlation***** as it calculates, as accurate as possible, the 
total electron density of the molecule.  HF does not explicitly calculate this effect but considers it in 
an average sense.142  The effect is that HF methods result in molecular orbitals where the electrons 
are slightly closer together on average.  This again results in an increase in the potential energy of 
the system due to an increase in electron-electron repulsion.   
The first ab initio level of theory that specifically calculates the effect of electron correlation is 
second order Møller-Plesset (MP2) perturbation theory.  In the DFT method the energy is expressed 
as a function of the density of a uniform electron gas E (ρ) rather than as wave functions.  This was 
then modified to express the electron density around the molecules.123,143  Some examples of 
density functional theory include BLYP and B3LYP.144,145  All the above methods are defined as 
the level of theory.  A “level of theory” cannot work on its own to perform calculations since the 
molecular orbitals (MOs) have not yet been described.  All electronic methods make use of basis 
functions.  Basis functions are sets of mathematical functions which are designed to describe the 
MOs and to provide maximum flexibility (subject to the cost of doing the calculation) to the 
molecular orbitals.  The basis functions are collectively called basis sets.  They are derived from the 
following equation (eqn: 3): 
 ψi = ∑nµ=1Cµiφµ. (3) 
Where, Cµi is a molecular orbital expansion which is chosen to optimize the shape of the basis 
function sum and to ensure normalization.   Lastly, φµ is a basis function of atomic orbitals. 
Increasing the flexibility of the basis set allows the mathematical algorithm, which solves the wave 
function of the molecule, to obtain lower energies as restrictions to the space occupied by the MO 
are removed.  
4.1  Choosing a basis set 
In early ab initio programs, it was a very tedious and error-prone task to specify a basis set for 
computations.  The user was required to punch several dozen floating point numbers into specific 
columns of the input deck without a single typing error.  With current programs like Gaussian,  
                                                                                                                                                                                                                     
§§§§ The term ab initio is a latin word which means “from the beginning”
***** Electron correlation is the phenomenon where the electrons in a molecular system avoid each other in the orbital and attempt 
to stay as far as possible apart.   
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HONDO,146 GAMESS,  and Jaguar  the user may select from among a wide variety of internally 
defined basis set by specifying the appropriate keyword (usually the basis set name).  
4.2  Types of basis sets 
The most widely calibrated basis sets for general purpose usage are those of Pople and co-workers, 
which range from the small STO-3G minimal basis set all the way up to basis sets with extra diffuse 
functions.  Besides their wide usage, these basis sets offer the computational advantage that, when 
used with computer programs that exploit their features, the calculation of the second and first 
derivative integrals is faster than for most other basis sets, because exponents are shared between    
s and p functions.123,139,147
There are mainly five types of basis set, minimal basis sets (contracted basis sets), split valence 
basis sets, polarised basis sets, high angular momentum basis sets and basis sets for post-third-row 
atoms. 
Minimal basis sets contain the minimum number of basis functions needed for each atom.  They use 
fixed-sized (contracted) atomic-type orbitals e.g. Slater type orbitals (STOs) and Gaussian type 
orbitals (GTOs).  Examples are STO-3G, MINI-1 and MINI-2.  STO-3G uses three Gaussian (3G) 
primitives per basis functions after Pople et al.148 discovered that the optimum speed and accuracy 
(compared to calculations using STOs) of calculations was achieved for M=3, where M is the 
number of Gaussians used in the linear combination of atomic orbtals.   The STO-3G basis set uses 
Slater type orbitals (STO).  This basis set was initially developed for the elements H-Ne, but as time 
went on it was expanded to cover Na-Ar, P-Kr, and Rb-Xe.149, , ,150 151 152   
In Split valence basis sets the number of basis functions per atom is increased which makes the 
basis set larger and increases its flexibility.  Examples are 3-21G, 6-21G, 4-31G, 6-31G, 6-311G 
and D95.153  The nomenclature is a guide to the contraction scheme.  The first number indicates the 
number of primitives used in the contracted core functions.  The numbers after the hyphen indicate 
the numbers of primitives used in the valence functions.  If there are two such numbers, it is a 
valence-double-ζ basis.   Split valence basis sets have two sizes of basis functions for each valence 
orbital, e.g. hydrogen and carbon can be represented as:   
H: 1s, 1s’. 
C: 1s, 1s’, 2s, 2s’, 2px, 2py, 2pz, 2px’, 2py’, 2pz’. 
It is important to note that primed and unprimed orbitals differ in size.  
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Polarised basis sets add polarisation functions into split valence basis sets.  Split valence basis sets 
only expand (change the size) the orbitals but do not change the orbitals shapes.  Polarized basis 
sets remove this limitation by adding orbitals corresponding to one quantum number of higher 
angular momentum than the valence orbitals.  They add d functions for atoms like C, N and O, 
while some add p functions to hydrogen atoms and f functions to transition metals.  It is important 
to note that the d functions that are added to C, N and O atoms have similar sizes to 2p orbitals and 
p functions in hydrogen atoms are also similar in size to the 1s orbital and so on.   The primary 
purpose of the polarization functions (d and p functions) is to give additional flexibility to the linear 
combination of atomic orbitals (LCAO) process in forming bonding orbitals between pairs of 
valence atomic orbitals (1s, 2s, 2p, etc).  Polarization functions are essential in strained ring 
compounds because they provide the flexibility needed to direct the electron density into regions 
between bonded atoms.  They can also be used for accuracy in unstrained compounds.  An 
important point is that most basis sets are defined to use five spherical d functions, except 6-31G(d) 
which uses six Cartesian d functions.  The six Cartesian d functions are dx2, dy2, dz2, dxy, dxz, dyz and 
pure spherical d functions are dz2- r2, dx2- y2, dxy, dxz, dyz.  Examples of polarized basis sets include   
6-31G(d) and 6-31G(d,p). 
Since highest energy molecular orbitals of anions, molecules with lone pairs, highly excited 
electronic states, and lose supermolecular complexes tend to be much more spatially diffuse than 
normal molecular orbitals, diffuse functions are needed to minimise errors in energy calculations of 
such systems.  To minimise this error in energy, standard basis sets like polarized basis sets          
[3-21G(d), 6-31G(d), etc] are often augmented with diffuse basis functions, which are indicated by 
adding ‘+’ in the basis set name.   Diffuse functions are typically a better treatment for cases where 
negatively charged species are being studied because the ionic radius of an anion increases 
significantly as compared with the corresponding neutral species.  Diffuse functions are large 
versions of s- and p-type functions.  Thus, 6-31+G(d) indicates that heavy atoms have been 
augmented with an additional s and an additional set of p functions.  A second ‘+’ in 6-31++G (d) 
indicates the presence of s functions on H as well.   
High angular momentum basis sets add multiple polarization functions per atom to the triple zeta 
basis set.  For example, the 6-31(2d) basis set adds two d functions per heavy atom instead of one d 
function.  The 6-31++G(3df, 3pd) basis set contains three sets of valence region functions, diffuse 
functions on both heavy atoms and hydrogens and multiple polarization functions (3p functions and 
1d functions) on hydrogen atoms.  These basis sets are useful for describing the interactions 
between electrons in electron correlation methods.  They are not generally needed for HF 
calculations. 
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Basis sets for post-third-row atoms are treated in a different way from normal basis sets.  In these 
basis sets for very large nuclei, electrons near the nuclei are treated in an approximate way, via 
effective core potentials, a method developed by Hellmann in 1935.154  Examples of these basis sets 
are LANL2DZ, LACVD, LAV2D and LACV3P, which are available in programmes like Jaguar.  
4.2.1  The Schrodinger equation and the energy surface of the molecule  
The aim of solving the Schrodinger equation is to obtain information about the structure and energy 
of the molecule being investigated.  These theoretical calculations mimic more closely the path of 
the reaction in experiments.  In order to get a better understanding of the reaction, all possible 
structures linking reagent to product should be considered.   The exploration of all structures 
corresponds to the characterisation of a full potential energy surface (PES) of the reaction path.  A 
potential energy surface is the energy obtained as a function of reaction coordinates in a chemical 
structure (i.e. rotation of single bonds and dihedral angles).  PES is normal taken as the potential 
energy in a two-dimensional energy profile.  
The classical example is the PES for butane found in text books.155  Below is an example of the 
PES for dibromoethane. 










































Figure 25: Energy profile of dibromoethane 
The staggered conformation (global minimum) has the lowest energy since the two bromo atoms 
experience the least steric hinderance and is sometimes called an anti comformer.   A gauche 
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conformer is higher in energy and is called a local maximum.  In cases of peptide modelling where 
there are many minimum structures, the structure that is native is referred to as the global 
minimum.   The eclipsed conformers are maxima on the energy profile and are also transition states.    
4.3  The optimization algorithm  
The optimization algorithm makes generally use of the energy surface of the specific molecule 
under investigation.  The algorithm calculates the slope of the energy surface and in the case of the 
search for a minimum, it will take a step towards the minimum.  The algorithm will then re-
optimise the structure by moving the atoms so that a structure with lower energy is obtained.  The 
slope of the energy surface is again calculated and the next “down hill” step is taken.  This is 
repeated until the slope eventually is reversed due to an overstepping of the minimum on the energy 
surface.  The algorithm will then take a step backwards and the process is repeated until the lowest 
energy structure is obtained. 
In the case of searching for a transition state, the same principle is used, except that the step is taken 
“up hill” as the transition state is represented by a maximum on the energy surface. 
Various modifications to the basic optimization algorithm exist which are designed to increase the 
efficiency of the optimization in terms of speed and quality.  It is important to note that most 
optimization algorithms are sensitive enough to be trapped in local minima.  If one starts with a 
transition state, a normal optimization searching for minima may even get trapped at the maxima 
and find exactly the same transition state structure.  Optimization algorithms such as Monte Carlo  
are designed not only to take a step down the energy surface, but also to randomly take a step in any 
direction.  This will enable the algorithm to find minima lower than a local minimum.    
4.4.  Searching for a transition state 
A transition state (TS) is a molecular species that is represented by the maximum on a potential 
energy curve in a two-dimensional reaction co-ordinate diagram.  In experimental cases it is 
difficult to predict the geometry of a transition state, however nowadays there are spectroscopic 
methods which can be used to determine the structure of the transition state, such as femtosecond 
pulse laser spectroscopy, although this is limited to specific systems.69,121  Therefore the whole 
process of transition state modelling still depends heavily on computational methods.  In order to 
locate maxima (transition states), it is necessary to have fairly accurate initial geometries and 
matrices of the second derivatives of the energy (e.g. Hessian matrix).   The reason for this is 
because a typical optimization algorithm performs a crude guess at the initial solution to the wave 
function of the molecule under investigation.  The optimization algorithm then starts a series of “up 
hill” iterations to solve the wave function.  If the initial structure is too far away from the correct 
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transition state, then the initial guess would not locate the correct wave function of the specific 
transition, leading to an incorrect solution.  
In order to obtain a transition state, it is important to know which reaction coordinates will need to 
be controlled in order to get the maximum.  Typical reaction coordinates may be bond 
breaking/formation, dihedral angle, angle or a combination of these.  A program for modelling 
structures between reactant and product could be used to perform a linear search for the lowest 
maximum on the energy surface.  A SCAN††††† calculation is used as the most convenient method 
to obtain a transition state, where an accurate starting structure for a transition state is found at the 
maximum of the potential curve.  The SCAN jobs increase/decrease bond length, angle or dihedral 
angle in a stepwise manner.  In each step of a SCAN calculation the molecule is optimised while 
only constraining the specified parameters.  Needless to say the method is quite expensive in terms 
of time.  A practical hint is to first use a crude scan where the step size is quite large, and then to 
“zoom” in closer to the maximum by using smaller step sizes in a subsequent scan job. 
The structure closest to the maximum on the energy surface is manually extracted and used as a 
starting structure for a non constrained transition state optimization.   
A frequency calculation is performed so as to confirm that the maximum structure is really a 
transition state by confirming that the movement of atoms associated with the transition (the 
negative eigenvalue/frequency) corresponds to the specific transition.  Imaginary frequencies are 
found in the output file as negative eigenvalues.‡‡‡‡‡  For a transition state only one imaginary 
frequency/negative eigenvalue is accepted, since it is a first order saddle point.   It may sometimes 
be difficult to say without doubt if the movement of atoms associated with the transition really 
corresponds to the correct transition.  When this happens the correctness of a transition state is 
determined by using the intrinsic reaction coordinate (IRC) method to find the minimum energy 
path (MEP) from the TS to the local minima on either side of the maximum.  
More experienced computational chemists prefer a shorter method to determine transition states.  
This is achieved by manually constructing a transition state input structure and performing a full 
unrestricted transition optimisation on it.  This method can be slightly modified by fixing the 
reaction coordinate at an approximate value, which is known from experience.  The rest of the 
molecule is optimised and then all constraints are released to find the real transition state.   
                                                                 
†††††  A SCAN job varies the presetted reaction coordinate moving the structure from reactant to product or vice versa.  
‡‡‡‡‡  “eigenvalues are set of scalars associated with a linear system of equation e.g. a matrix equation”.
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4.5 The solvent effects 
A“Gas phase”§§§§§ calculation excludes solvent effects and is a simplified technique of obtaining the 
information about the molecule under investigation.  Once a clear understanding of the behaviour of 
the molecule is obtained through gas phase calculations, one can include computational methods to 
mimic the effect of surrounding condensed phase.  The theory to approximate the effect of solvents 
were developed in the late 1980s and are still currently used.  If the theory was only restricted to gas 
phase calculations, it would have been inapplicable to vast tracts of chemistry and biochemistry.  
Since most chemical reactions are performed in solution, it is important to consider the effect of the 
solvent on the behaviour of the system.  In some cases solvents are so tightly bound that they can be 
a fundamental part of the solute.  Those systems are modelled explicitly, but there are cases where 
solvent does not interact with the solute, but it acts as a “bulk medium” which also affect the 
behaviour of the solute.    
There are different methods that are used to introduce solvent effects in the quantum mechanical 
optimization of molecules in solution viz:  The polarisable continuum model (PCM) developed by 
Tomasi et al.156 and the Onsager self-consistent reaction field (SCRF) model.157  PCM represent a 
cavity in which the solute is embedded by a solvent and it also represent a tool to accurately 
describe the effects of solution on the molecle under investigation.158  The aim of the continuum 
solvent models is to acts as a perturbation on the gas-phase behaviour of the system.   In the SCRF 
model the solute-solvent interaction is treated as a perturbation of the Hamiltonian of the isolated 
molecule.  The solute is assumed to occupy a spherical cavity of radius a0.
159  In this study Jaguar  
at the B3LYP/6-31+G(d) level was first used for optimizations in the gas phase.  The calculation 
was then repeated starting with the optimised “gas phase”structure and the solvent is selected from 
the program.  The radius of the spherical cavity a0 is automatically included in the optimization.  
Solvent effects often play an important role in determining equilibrium constants and reaction rates 
(i.e. activation energies).   In an SN2 mechanism the rate of the reaction can be determined by the 
type of solvent used, e.g. if a reaction involves an alkyl halide and a neutral nucleophile, increasing 
the polarity of the solvent will increase the stability of the transition state, because the charge on the 
transition state will be higher than that of the neutral reactants.   While using a non polar aprotic 
solvent in a charged transition state will destabilise the transition state by increasing its activation 
energy. 
                                                                 
§§§§§ The term “gas phase” means in vacuo. 
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4.6 Previously reported results and considerations 
Previous “gas-phase” ab initio studies by the organic research group at UKZN were undertaken for 
the acetylation of amines and alcohols with anhydrides, using density functional theory (DFT), 
Restricted Hartree Fock (RHF) and second order Møller-Plesset (MP2) levels of computation.  
These studies suggested the formation of a precomplex that preorganizes the molecules in a 
favourable orientation that facilitates the formation of a six-membered ring transition state of acetic 
anhydride with the reagents.   In all these investigations the model neglected the effect of solvent 
and catalyst for simplicity.  The six-membered cyclic transition state was found to be independent 
of the level of theory and basis set used.108,109,110  The model was also applied successfully to the 














































































Figure 26: The δ-lactam with possible acetylation products  
The computational model has revealed that the transition state reading to 98a is both kinetically (by 
2.5 kcal. mol-1) and thermodynamically preferred product (by 2.8 kcal. mol-1) over the nearest 
possible isomer.   The theoretical predictions correlated with the experimental results since it was 
experimentally observed that 98a is obtained between 25-30°C, while a mixture of the monoacetate 
98a and the diacetate 99 is obtained at 38°C.29,110  
The model was extended to include various hydantoin systems.  The same cyclic transition state  
was obtained for all three hydantoin compounds 100, 101, and 102, both at the N-1’ and N-3’ 
positions.  Some precomplexes  for the PCU lactam systems between hydantoin and acetic 
anhydride 97, could not be obtained.  Note that the three hydantoin systems 100, 101, and 102 
exhibit increasing steric hindrance.  It was expected that protection would preferentially occur at the 
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more nucleophilic but more sterically hindered nitrogen (N-1’), since N-3’ is less nucleophilic 






























Figure 27: Protection of hydantoins, N-1’ versus N-3’ 
Diastereomeric effects were considered in these calculations as it was shown by Govender et al.  
that chiral alcohols and amines form diastereomeric transition states with anhydrides (Figure 27).  It 
































Figure 28: Chiral diastereomeric transition states for a chiral amine 
According to the computational results protection of 5-methylhydantoin 100 at N-1’ of the 
hydantoin ring was found to be both kinetically (-1.4 kcal.mol-1) and thermodynamically (-0.1 
kcal.mol-1) favoured over the closest competing alternative route.  The same preference was 
observed in 5,5-dimethylhydantoin 101, where protection at N-1’ was both kinetically (0.3 
kcal.mol-1) and thermodynamically (-23.3 kcal.mol-1) favoured.  The justification for these 
preferences seems logical as it was mentioned above that although N-1’ experiences more steric 
hindrance, it is more nucleophilic than N-3’ which favoured protection over N-3’. 
In contrast it was found  that protection of the PCU hydantoin 102 at N-3’ is both kinetically (2.5 
kcal.mol-1) and thermodynamically (2.0 kcal.mol-1) favoured.  It is clear that the larger steric 
hindrance imposed by the rigid PCU skeleton forced protection away from the stronger nucleophilic 
nitrogen (N-1’) towards the less hindered but also much less nucleophilic nitrogen (N-3’).    
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The purpose of this investigation was to investigate the possibility of a similar six membered ring 
transition state for the esterification reaction of alcohols with acetic acid and acetyl chloride.    
4.7  Computational methodology and discussions 
Gas-phase studies were undertaken using the Gaussian 03  and Jaguar  programmes at the DFT 
(B3LYP)144,145 level of theory with the 6-31+G(d) basis set.  The effects of solvent and entropy in 
the reactions were considered but catalytic effects were ignored for simplicity.  The model mimics a 
normal Fischer esterification49,160 reaction.  The model was further simplified by using methanol, 
acetic acid and acetyl chloride to reduce the use of computational resources and time.   
Modern textbooks160,161 are teaching slight variations of a linear stepwise mechanism for the 
esterification reaction of an acid with an alcohol (Scheme 19).  The carbonyl oxygen of 88 is first 
protonated by an acid at higher temperatures.  The reaction proceeds through the carbocation 
intermediates 104, 105 and 106 and the ester 92 is formed after a series of steps.  A similar linear 















































Scheme 19: Mechanism of esterification160,161
It was previously reported,108,110 that linear transition states for the protection of alcohols (and 
amines) with acetic anhydride are not stationary points on the energy profile of a “gas phase” 
calculation excluding solvent and catalytic effects, therefore this claim had to be verified for the 
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reaction presented in Scheme 19.  Intermediate cation structures such as 104, 105, 106 and 109 (see 
Scheme 19) are supposed to be minima on the energy surface of the reaction when presented as 
intermediates in the reaction.   
All the carbocations fall apart during an optimization, to its corresponding precursors when 
optimized in both the “gas phase” as well as when solvent effects are considered (computational 
results optained in this investigation).  This indicates that the conventional mechanism above is 
problematic as it is accepted that the carbocations are intermediates****** in the reaction.  The 
computational result is in fact not contrary to what we are taught in organic lectures.  It is generally 
accepted that cations such as 104, 106 and 109 will automatically lose a proton to the solvent, while 
105 will lose water.  However, the mechanism as taught in Scheme 19 implies that those cations 
should be stationary points in terms of computational chemistry (even a transition state is a 
stationary point!).  This is clearly the case for the gas phase and we know from theory that it is less 
likely that it will be stationary points in solution, as the solvent will automatically neutralise the 
excess charge on the substrate by either removing a proton or providing a proton.  It is also apparent 
that these carbocations will have much higher energies than neutral species, that is after all the 
reason why they would automatically lose charged atoms/fragments to the solution, as it is a 
thermodynamically driven process.  One can therefore rightly state that the mechanism of 
esterification deserves a fresh theoretical investigation.  In order to postulate a six membered ring 
transition state for this Fischer esterification reaction (Scheme 19), the selective use of one solvent 
molecule (methanol) is required.  This is a reasonable assumption as the reactants will be 
completely surrounded by methanol   
There are two types of mechanism proposed in this investigation for the reaction of methanol with 
acetic acid and acetyl chloride: 
(i) two one step concerted mechanisms which go straight to products i.e. a four-membered ring 
and six-membered ring transition states (Scheme 20)  
(ii) A step-wise mechanism which takes place through a stable intermediate (Scheme 21). 
The discussion below will focus on the acetylation reaction using methanol and acetic acid.  The 
same mechanism can be extrapolated to the esterification of methanol with acetyl chloride.  For 
both the concerted and step-wise mechanisms of ester formation, the first transition state involves 
simultaneous nucleophilic attack by the alcohol oxygen on the carbonyl carbon                   
(i.e. partial O1----C2 bond formation) and partial transfer of an alcohol hydrogen (H4) to the 
                                                                 
******  An intermediate is a structure that can not necessarily be isolated, but it is stable enough to exist for a short time.  An 
intermediate in terms of computational chemistry should by definition therefore be a stationary point (maxima or minima) on the 
energy profile.  
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carboxylic acid oxygen atom (i.e. partial X3----H4 bond formation).  Simultaneous transfer of H6 

































(X = OH, Cl)
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Scheme 20: Proposed one step concerted mechanism 
In the six membered cyclic transition state (Scheme 20, TS-6.1-OH) both O1----C2 bond formation 
and the release of water and a methanol molecule will take place simultaneously.  A four membered 
ring transition state (Scheme 20, TS-4-OH) is also apparent.  It is expected that the relative 
activation energy of the four membered ring transition state (TS-4-OH) will be higher that of the 
six membered ring (TS-6.1-OH) due to higher ring strain. 
In contrast to the concerted mechanism (Scheme 20), the step-wise mechanism (Scheme 21) is 
assumed to take place through a stable intermediate (Scheme 20, Int-OH).  In the first step the 
transition state (TS-6.2-OH), represents the O1----C2 bond formation through the nucleophilic 
attack of the methanol oxygen atom on the carbonyl carbon atom.  Similar hydrogen transfer as 
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Scheme 21: Proposed step-wise mechanism 
In the second step, the intermediate (Int-OH) is converted to the product through a similar six 
membered cyclic transition state (TS-6.3-X), in which water and methanol are released to form the 
products.  Analogous mechanisms are possible for the acteyl chloride reaction.   
Geometry optimizations were performed without any constraints using B3LYP/6-31+G(d) so as to 
find the lowest energy structures for the reactants, intermediates, transition states and products.  
Cyclic transition states were characterized by single imaginary frequencies which were associated 
with the movement of atoms consistent with the expected transition.  The transition states seem to 
belong to a class of pseudopericyclic transition states reported before by Birney et al.162   It is 
beyond the scope of this study to compare the similarities and difference between pseudopericyclic 
transition states and the cyclic transition states reported herein.  As pointed out before,  special 
attention should be paid to these cyclic transition states (TS-4-X, TS-6.1-X, TS-6.2-X and TS 6.3-
X) as the carbonyl carbon is chiral during the formation of the transition state.  At least two possible 
transition states exist for each of TS-4-X and TS-6.3-X.  At least four transition states exist for each 

































































































































* * * *
 
Figure 29: Diastereomeric cyclic transition states (X = OH, Cl)163
It is important to note that all the possible diasteriomeric (and enantiomeric) transition states lead to 
one product (ester) only.  The six mechanisms (Schemes 20, 21 and Figure 29) were modelled and 
the results are presented in Table 1.  The Cartesian coordinates of all optimised structures are 
available as supplementary material on the attached CD.   
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Table 1: ∆E vs ∆G in gas phase and in solution 
 Relative energiesa,b using B3LYP/6-31+G(d) / kcal.mol-1
 X = OH X = Cl 
 “Gas Phase” MetOH “Gas Phase” MetOH 
 ∆H ∆G ∆H ∆G ∆H ∆G ∆H ∆G 
Reactantsc 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
TS-4.1-Xd 41.2 11.7 47.9 11.5 16.0 11.3 12.9 10.6 
TS-4.2-Xd 45.4 11.6 50.4 11.8 21.2 11.2 15.0 10.7 
Productse -2.0 1.0 -2.7 2.3 -12.5 1.7 -10.0 2.9 
Reactantsc 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
TS-6.1.1-Xd 29.3 22.4 36.8 24.2 2.2 22.0 9.2 23.1 
TS-6.1.2-Xd 28.0 22.5 36.9 23.2 2.3 21.9 9.5 23.0 
TS-6.1.3-Xd -f -f -f -f 3.7 22.6 10.5 22.6 
TS-6.1.4-Xd -f -f -f -f 5.8 22.3 10.5 22.6 
Productse -2.0 1.0 -2.7 2.3 -12.5 1.7 -9.9 2.9 
Reactantsg 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
TS-6.2.1-Xh 19.4 23.0 32.4 22.4 -4.7 21.8 0.7 22.4 
TS-6.2.2-Xh 18.8 22.8 32.1 23.2 24.5 22.7 10.5 23.2 
TS-6.2.3-Xh 19.3 23.1 32.2 23.7 -f -f -f -f
TS-6.2.4-Xh -f -f -f -f 16.6 23.3 9.3 22.8 
Int-Xh 5.5 11.9 11.4 12.2 0.3 12.1 4.6 12.1 
TS-6.3.1-Xh 18.7 23.0 32.8 22.4 -13.7 22.5 -14.8 22.0 
TS-6.3.2-Xh 18.3 23.0 32.0 24.3 -10.3 22.6 19.1 23.5 
Productsi -2.0 1.0 -2.7 2.3 -12.5 1.7 -10.0 2.9 
a Energy reported at the same level of theory used for the optimization.  The Cartesian coordinates of all optimised structures are available 
as supplementary material on the attached CD. 
b. All energies are reported relative to the sum of energies of the reactants. 
c. 2 CH3OH + CH3COX (refer to Scheme 20). 
d. Refer to Scheme 20. 
e. CH3OH + CH3COOCH3 + H2O or HCl (refer to Scheme 20). 
f. One of the methyl groups flipped over during the transition state optimization.  
g. 2 CH3OH + CH3COX (refer to Scheme 21). 
h. Refer to Scheme 21. 
i. CH3OH + CH3COOCH3 + H2O or HCl (refer to Scheme 21). 
Four-and six-membered ring cyclic transition states were obtained for methanol, acetic acid and 
acetyl chloride.  The second methanol molecule assisted in facilitating the six membered ring 
transition states.108,109,110  According to the results in Table 1, values for a change in free energy 
(∆G) shows clearly that the four-membered ring transition states (TS-4-X) are energetically 
preferred when compared to the six-membered ring transition states (TS-6.1-X), while the opposite 
is true when entropy effects (∆S) are ignored.   
The fact that four membered rings are more strained  increases the activation energy as ∆H 
considers bond energies, while six membered rings are expected to be less strained and show 
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smaller ∆H values.  As the six membered ring transition states involve a solvent molecule, the 
disorder is decreased leading to an expected decrease in entropy.  It is somewhat surprising that this 
entropy effect is so large to reverse a much favourable kinetic preference of the six membered ring 
transition states when entropy is ignored.  Since four membered rings are small compared to six 
membered rings, the former have much higher randomness in terms of translational, vibrational and 
rotational energies, which increase the entropy of four membered ring system.   
The acetyl chloride mechanism is energetically favoured in all respects as is expected.  The Gibbs 
kinetic energy results in Table 1 shows that the esterification mechanism with acetyl chloride in the 
gas phase is marginally favoured over acetic acid for both the four membered ring (0.4 kcal.mol-1) 
and the concerted six membered ring mechanism (0.4 kcal.mol-1).   
The six membered ring step-wise mechanism and concerted mechanism have similar Gibbs kinetic 
energy values for both gas phase and including solvent effects. 
Esterification with acetic acid may need mild heating conditions, as it is known  that molecules have 
enough thermal energy at room temperature to allow processes requiring up to ∼15 kcal.mol-1.   
The reason for the dominance of acetyl chloride mechanism may be because chlorine is a better 
leaving group than hydroxide (-OH), and is also a weaker base.  The intermediate (Int-OH) for 
acetic acid mechanism is preferred by 0.3 kcal/mol over the acetyl chloride intermediate.  Similarly 
the products for the acetic acid reactions are more stable than for acetyl chloride.   
The esterification experiment is normally performed in a polar protic solvent (methanol).  Since the 
concerted mechanism model of the Fisher esterification (see Scheme 20) represents a normal SN2 
mechanism, the same stabilization effect by a polar solvent is expected.  This stabilization is 
observed for the acteyl chlorie reaction (see Table 1), but not for the acetic acid reaction. 
Since in theory, the entropy change in gas phase (∆S >>0) is higher than the entropy change in 
liquid phase (solution), i.e. the randomness of the gas phase system is higher than that in a liquid 
system, therefore the free energy in a gas phase is expected to be more negative implying the 
spontaneousity of the reaction in gas phase than in solution.  The solvent effect plus entropic effect 
can cause the reaction performed in solution to have a higher free energy than in the gas phase,164 
since there is a decrease in number of participating species (the molecules are trying to be ordered).  
This is likely to cause a decrease in entropy (∆S <<0).165  This may result in a greater value of 
  55
∆G.††††††  The effect of a decrease in entropy is observed in the six membered ring reactions only 
(see Table 1). 
 
                                                                 




The first part of the thesis involves the synthesis of cage amino acids and the incorporation into 
peptides.  The synthesis of a trishomocubane amino acid 14 and its Fmoc derivative was 
successfully performed.  The Fmoc-tris amino acid fluoride 78 was also synthesised.  Acid fluorides 
are crucial for the incorporation of sterically hindered α,α-amino acid derivatives into short 
peptides.  An excess of 78 and prolonged reaction times are necessary for the successful coupling of 
the cage amino acid to peptides.  The synthesis of the tri-peptide (Ala-Ala-Ala, 69) was successful 
and it has been useful in obtaining experience in the SPPS method.  Ala-Ala-Ala-tris 79 was 
successfully synthesized in 40% yield according to HPLC analysis.  The successful synthesis of the 
tetra-peptide encouraged the incorporation of the cage moiety into the centre of the hepta-peptide 
(Ala-Ala-Ala-tris-Ala-Ala-Ala, 80).  The mass spectroscopy results confirmed the successful 
synthesis of the hepta-peptide with a peak at m/z = 631which corresponded to the molecular mass 
of the peptide 80 (630.74 g.mol-1).  Seven different carbonyl peaks were observed in the 13C NMR 
spectrum of 80 at 155.36, 170.93, 171.38, 171.54, 171.59, 174.16 and 174.18 ppm.  The experience 
gained in this study was communicated to our collaborators in Sweden and a sample of the amino 
acid 14 was also sent to them.  They were able to synthesise the peptide 80 in pure form recently 
and separated both diasteriomeric peptides using preparative HPLC.  The X-ray structure of each 
peptide was also obtained and correspond well with the previously predicted structures.   
The second part of the thesis involved a theoretical investigation of esterification reactions.  
Esterification mechanisms were proposed for acetyl chloride, acetic acid and methanol.  A 
concerted four membered ring and six membered ring mechanism was considered.  The use of an 
additional methanol molecule from the solvent facilitated the formation of the six membered ring 
transition states.  A step-wise reaction mechanism involving six membered ring transition states was 
also investigated.  Calculations were performed in both the “gas” phase and in solvent.  As 
expected, the four membered ring transition states were higher in energy, although the disadvantage 
is overcome when entropic effects are considered.  The six membered ring transition states 
experience a huge entropy penalty, making the four membered ring mechanism favoured in terms of 
Gibbs energy.  The activation energy of the reaction (∼11 kcal.mol-1) is just inside the range of a 
spontaneous reaction at room temperature, provided that the by-products are removed.  The 
proposed mechanism does not include any carbocation intermediates.  The computational results 
suggest that the carbocation intermediates which are still proposed in modern text books are not 




Melting points were recorded using a Bombay 400 013 instrument from Shital Scientific Industries.  
All melting points are uncorrected.  Infrared spectra (IR) were obtained using a single beam Nicolet 
Impact 410 spectrometer.  The one-dimensional NMR spectra were recorded on a Varian Gemini 
300 MHz spectrometer.  The fast atom bombardment (FAB) mass spectra were obtained from a 
Micromass VG70-70E mass spectrometer at North-West University (Potchefstroom campus), 
equipped with an In-tech FAB gun.  FAB mass spectra were obtained by bombardment of samples 
with xenon atoms (1 mA at 8 keV).  m-Nitrobenzyl alcohol was used as the matrix.  Elemental 
analysis was done using a Leco CHNS 932 instrument.  HPLC analysis was performed using a 
Waters model 510 solvent delivery system and SP8490 detector.  A Nucleosil 100 C18 column (5 
µm particle size, 250 mm x 4.6mm i.d.) was used.  The details for the HPLC solvent conditions are 
provided below at the relevant section.  All the experimental work was performed by the author in 
the laboratory. 
6.1  Synthesis of 5,8-methano-4a,5,8,8a-tetrahydro-1,4-naphthoquinone (18, adduct) 
p-Benzoquinone 16 (200 g, 0.54 mol) was dissolved in dry toluene (4 l) and stirred in an ice/salt 
bath within a dark fume hood.  Cold, freshly cracked cyclopentadiene 17 (132 ml, 1.96 mol) was 
slowly added over two hours via a dropping funnel.  The slow addition and cool temperatures 
allowed for a successful Diels-Alder reaction, without dimerisation of the cyclopentadiene or 
diadduct formation.  The reaction was stirred overnight.  The solution was evaporated in a dark 
fumehood using an evaporating dish, and greenish-yellow crystals of an adduct were obtained.  The 
product was recrystallized from petroleum ether (40-60°C) to yield 18 as yellow crystals. (230 g, 
74%, Mp. 77°C).  NMR and IR were identical to those of an authentic sample. 
6.2 Synthesis of pentacyclo-[5.4.0.02,6.03,10.05,9]-undecane-8,11-dione (19)33,69
The adduct 18 (200 g, 1.15 mol) was added to a volumetric flask and dissolved in a (5 l) solution of 
10 % (v/v) acetone in hexane.  The volumetric flask was exposed to direct sunlight until a 
colourless solution was obtained.  The photocyclisation normally takes three to five days in Durban.  
The absence of the starting meterial was confirmed by TLC (4:96) of hexane in ethyl acetate.  The 
solvent was evaporated in vacuo to give a white, microcrystalline solid of 19 (195 g, 98%, Mp. 
240°C).  NMR and IR were identical to those of an authentic sample.  
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6.3 Synthesis of pentacyclo-[5.4.0.02,6.03,10.05,9]-undecane-8,11-dione-mono-ethylene 
ketal (28)  
A mixture of the diketone 19 (183.00 g, 1.05 mol ), ethylene glycol (81.20 ml, 1.45 mol),               
p-toluenesulfonic acid (6.11 g, 3.21x10-2 mol) and 4Å freshly regenerated molecular sieves (2 g) in 
dry toluene (800 ml) was gently refluxed with stirring in a Dean and Stark trap for four days.  The 
reaction mixture was left to cool and poured slowly into ice-cold 10 % (m/v) aqueous sodium 
carbonate (1 l).  The aqueous mixture was extracted with dichloromethane (3 x 500 ml).  The 
combined organic extracts were dried over anhydrous sodium sulphate.  The mixture was filtered 
and the solvent evaporated in vacuo.  The resulting brown residue was recrystallised from n-hexane 
to give 28 as a white solid (170 g, 74 %, Mp. 73ºC).  NMR and IR were identical to those of an 
authentic sample.31,69  
6.4 Synthesis of 11-hydroxypentacyclo-[5.4.0.02,6.03,10.05,9]-undecane-8-one-ethylene 
ketal (29)31,64  
The mono-ketal 28 (10.00 g, 4.59x10-2 mol) was dissolved in ethanol (100 ml) and placed in an ice-
bath to cool.  An ethanolic solution of sodium borohydride (3.50 g in 50 ml ethanol) was added, 
with stirring, over a 10 minute period.  The mixture was left to stir for two hours in an ice-bath and 
an additional two hours at room temperature.  A small amount (1 ml) of the mixture was withdrawn 
from the flask and extracted with dichloromethane to confirm complete reduction of the keto 
functional group using IR spectroscopy.  The solvent was removed in vacuo, and the residue 
extracted using dichloromethane (50 ml).  A white solid 29 was obtained in good yield (7.80 g, 
78%, Mp. 250°C).  NMR and IR were identical to those of an authentic sample.  
6.5 Synthesis of 11-hydroxypentacyclo-[5.4.0.02,6.03,10.05,9]-undecane-8-one (30)  
The hydroxy-ketal 29 (92.5 g, 0.42 mol, 27) was placed in an ice-bath at which stage 10 % (v/v) 
hydrochloric acid (200 ml) was cautiously added.  The mixture was stirred at room temperature for 
18 hours.  The product was extracted with dichloromethane (150 ml), the organic layer was dried 
with anhydrous sodium sulphate and evaporated in vacuo to yield 30 in good yield (89.5 g, 96%, 
Mp. 255°C).  NMR and IR were identical to those of an authentic sample.  
6.6 Synthesis of endo-pentacyclo-[5.4.0.02,6.03,10.05,9]-undecane-8-ol (31)64,65
A mixture of the hydroxyketone 30 (13.00 g, 7.52x10-2 mol) and hydrazine hydrate (23.10 ml, 0.74 
mol) in 1,2 ethane diol (200 ml) was refluxed, with stirring, at 120°C for two hours.  The mixture 
was allowed to cool to 80°C at which stage excess KOH (12.00 g, 0.21 mol) was added cautiously.  
Excess hydrazine hydrate and water was distilled from the mixture until the temperature reached 
185°C.  The mixture was refluxed for a further three hours at 185°C.  The mixture was cooled, 
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diluted with water (300 ml) and extracted with dichloromethane (3x100 ml).  The combined organic 
extracts were evaporated in vacuo.  A yellow residue was steam distilled to yield the alcohol 31 as a 
white solid with a distinct camphor-like smell (11.2 g, 56.3%, Mp. 231°C).  NMR and IR data were 
identical to those of an authentic sample. 
6.7 Synthesis of pentacyclo-[6.3.0.02,6.03,10.05,9]-undecane-4-ol (27)31,64,69
The alcohol 31 (31.2 g, 0.195 mol) was dissolved in glacial acetic acid (360 ml) containing (9 g) of 
concentrated sulphuric acid and the mixture was refluxed for 6 hours.  (The mixture turned black in 
colour after few minutes of refluxing).  The reaction mixture was cooled, diluted with 1500 ml of 
water and extracted with dichloromethane.  The organic extract was washed successively with water 
and sodium bicarbonate solution.  Decolourization was achieved by heating an organic extract with 
activated charcoal and subsequent filtration.  Evaporation of the solvent in vacuo resulted in 
pentacyclo-[6.3.0.02,6.03,10.05,9]-undecane-4-acetate (orange oil, 32).  The orange oil 32 was stirred 
overnight in a mixture of methanol (330 ml) and K2CO3 (18 g).  The volume of the methanol 
mixture was reduced in vacuo, diluted with water and extracted with dichloromethane.  The organic 
extract was dried and evaporated in vacuo to afford a white solid alcohol 27 in good yield (20.6 g, 
66%, Mp.167 -168oC).  NMR and IR were identical to those of an authentic sample.31,69
6.8 Synthesis of pentacyclo-[6.3.0.02,6.03,10.05,9]-undecane-4-one (12) 
Chromium trioxide (14.00 g, 0.14 mol) was dissolved in deionised water (30 ml) and added to 
acetic acid (320 ml).  The alcohol 27 (10.00 g, 0.0625 mol) was dissolved in acetic acid (100 ml) 
and added drop-wise to the prepared mixture.  The reaction was refluxed at 90ºC overnight.  The 
successful oxidation (Jones oxidation) of the alcohol was evident through reduction of Cr6+ (dark 
red) to Cr3+ (green).  The reaction mixture was cooled, diluted with deionised water (1000 ml) and 
extracted with dichloromethane (800 ml).  The organic extract was successively washed with water 
(2 x 500 ml), a saturated bicarbonate solution (2 x 500 ml) and water (500 ml).  The organic 
solution was dried, using anhydrous sodium sulphate.  The mixture was filtered, and the solvent 
removed in vacuo to yield pentacyclo-[6.3.0.02,6.03,10.05,9]-undecanone 12 (7.5 g, 76%, Mp. 195°C).  
NMR and IR were identical to those of an authentic sample.30,69
6.9 Synthesis of Tris-hydantoin (13) 
A mixture of NaCN (1.00 g, 2.04x10-2 mol), trishomocubanone 12 (1.00 g, 6.25x10-3 mol) and 
(NH4)2CO3 (2.00 g, 2.08x10-2 mol), ethanol (10 ml) and NH4OH (15 ml) were first stirred and 
sealed in a glass medium-pressure vessel.  The reaction vessel was sealed in a metal pressure vessel 
and partially filled with water.  The reaction vessel was placed in an oil bath and heated to              
60 -100 ºC overnight.  The cooled reaction was first diluted with deionised water (100 ml) and 
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extracted with ethyl acetate (150 ml).  The solvent was removed in vacuo to afford the crude 
hydantion (13).  The product was washed successively with acetone and diethyl ether and thereafter, 
recrystallised from tetrahydrofuran (THF) to yield pure hydantoin 13 as a white solid (1.4 g, 98% 
yield, Mp. 230°C).  NMR and IR were identical to those of an authentic sample.30,69  
6.10 Synthesis of bis-t-Boc protected Tris-hydantoin (45)30,46
The method was adopted from the literature.73,74  A solution of tris-hydantoin 13 (0.50 g, 2.17x10-3 
mol), di-tert-butyl-dicarbonate (1.19 g, 5.43x10-3 mol), 4-dimethyl-aminopyridine (DMAP) (1.3 
mg, 1.09x10-4 mol) and triethylamine (0.35 ml, 2.60x10-3 mol) in dry THF (50 ml) was left to stir 
under nitrogen gas for 24 hours.  The solution was concentrated in vacuo to yield the crude product.  
Purification was achieved through silica gel column chromatography (dichloromethane) to yield the 
product as a white powder 45 (0.77 g, 98%, Mp. 227 °C).  NMR and IR data were identical to an 
authentic sample.30,69
6.11 Synthesis of Trishomocubane amino acid (14) 
The method for the synthesis of trishomocubane amino acid was adopted from the synthesis of 
adamantanine (Scheme 4).   The method required the synthesis of hydantoin 13 from 
trishomocubanone 12 and hydrolysis of the hydantoin at high temperatures to the amino acid 14.   
The poor yield obtained with this method challenged the research group to search for another 
method that could produce 14 in good yield.  The solution was the bis-t-Boc protection of the 
precursor (hydantoin-13) by di-tert-butyl dicarbonate to form bis-t-Boc hydantoin 45.  Hydrolysis 
of the bis-t-Boc hydantoin was found to produce a good yield of trishomocubane amino acid (> 95 
% yield).  Both methods are presented below. 
6.11.1 Synthesis of Tris-amino acid (14) from the Tris-hydantoin (13) 
Trishomocubane hydantoin 13 (0.1 g, 4.88 x 10-4 mol) was added to a 100 ml beaker, 50 ml of 10% 
NaOH solution was added.  The mixture was then transferred to a metal pressure vessel which was 
heated with stirring at 170°C for 12 hours.  The yellow solution was cooled, acidified with 
concentrated hydrochloric acid to ~ pH 6.5.  The white precipitate of 14 formed.  The volume of the 
solution was then reduced to 20 ml (on a steam bath) to precipitate more amino acid.  The white 
product (0.06g, 60 %) of 14 was obtained, filtered and washed with diethyl ether, acetone and dried 
in a vacuum desiccator.   
The ninhydrin test was positive and confirmed the presence of the free –NH2 group.  IR (KBr) vmax, 
3436 cm-1, 3198 cm-1, 2953 cm-1, 2873 cm-1, 1623 cm-1, 1591 cm-1 and 1494 cm-1. 
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6.11.2  Synthesis of Tris-amino acid (14) from a bis-t-Boc Tris-hydantoin (45) 
The procedure was adopted from Rebek et al.   The bis-t-Boc hydantoin 45 in aqueous LiOH (8 mol 
equivalents, 1.560M) was stirred in a round bottom flask at room temperature overnight.  The 
resulting solution was adjusted to ∼pH 6.5 using concentrated HCl.  The trishomocubane amino 
acid 14 precipitated from solution and was filtered off to remove the water and by-products.  The 
product (14, > 95%) was washed with acetone and diethyl ether.  The ninhydrin test was positive.  
IR data was identical to an authentic sample.30,69
6.12 Synthesis of Fmoc-Tris amino acid (50)31,69
To an ice cooled solution of amino acid 14 (0.10 g, 4.88x10-4 mol) in 1,4-dioxane (7.50 ml) and 
10% (m/v) Na2CO3 (20 ml) was added, with stirring, a solution of 9-fluorenylmethylchloroformate 
(Fmoc-Cl, 015 g, 5.80x10-4 mol) in 1,4-dioxane (5.00 ml).  This was left to stir in the ice-bath for 
four hours and at room temperature for a further eight hours.  The solution was diluted with 
deionised water (50 ml) and extracted with diethyl ether (100 ml).  The aqueous layer was cooled to 
10°C in an ice-bath and acidified to pH 2 with concentrated HCl.  The solution was subsequently 
extracted with ethyl acetate (150 ml).  The organic solvent was evaporated in vacuo to give the 
crude Fmoc amino acid derivative 50.  Purification was achieved using a silica gel column 
chromatography (dichloromethane) and (0.16g, 75%, Mp. 213°C) of the product was obtained as 
white solid.  .  Elemental analysis, Found: %C=75.83, %H=5.95, %N=2.92; C27H25NO4 (427.178), 
required %C=75.86, %H=5.89, %N=3.28%.  NMR data was identical to an authentic sample.30,31  
IR(KBr) vmax, 3417 cm-1, 3358 cm-1, 2954 cm-1, 2880 cm-1, 1744 cm-1, 1711 cm-1, 1419 cm-1, 737 
cm-1.  M.S. data m/z=428  
6.13 Synthesis of Fmoc Tris-amino acid fluoride (78)45,69  
Cyanuric fluoride (40.50 µl, 4.68x10-4 mol) was added to a suspension of Fmoc tris amino acid 50 
(0.20 g, 4.68x10-4 mol) and dry dichloromethane (50 ml).  Dry pyridine was added (37.80 µl, 
4.68x10-4 mol) and the resulting solution was left to stir under nitrogen for 12 hours.  Precipitated 
water-soluble cyanuric acid was extracted with ice water (40 ml).  The organic phase was dried over 
anhydrous MgSO4, filtered and removed in vacuo.  The resulting white solid was recrystallised 
from dichloromethane/hexane to give the pure acid fluoride as a white solid (0.17 g, 87 %). The 
NMR data was identical to those of an authentic sample.  IR (KBr) vmax, 3414 cm-1, 2971 cm-1, 
2869 cm-1, 1841 cm-1 (-CO-F), 1729 cm-1, 1614 cm-1, 741 cm-1.   
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6.14  Coupling of linker to MBHA resin  
The MBHA resin 64 (0.50 g, 0.70 mmol NH2/g) was swelled by adding DMF to a 10 ml 
polypropylene syringe.  The FmocAM linker 65 (0.47 g, 8.75x10-4 mol), DIPCDI 67 (0.14 ml, 
8.75x10-4 mol) and HOBt 66 (0.12 g, 8.75x10-4 mol) were added at room temperature to the resin 
in DMF.  This was left to stir for 24 hours.  Successful attachment was confirmed by a negative 
ninhydrin test.   The Fmoc group was cleaved by stirring the resin and linker in 20 % (v/v) 
piperidine in DMF for 30 minutes.  Cleavage of the Fmoc group was confirmed by a positive 
ninhydrin test.  The Fmoc by-product was removed from the solution by filtration, followed by 
washing‡‡ of the resin with isopropanol and DMF. 
6.15 Washing procedure for solid phase peptide synthesis 
The resin was washed with DMF (3 x 10 ml, 30 sec), isopropanol (3 x 10 ml, 30 sec) and DMF (3 x 
10 ml, 30 sec).  
6.16 Coupling of Fmoc Alanine to the solid support 
  
Fmoc Alanine, DIPCDI (0.14 ml, 8.75x10-4 mol) and HOBt (0.12 g, 8.75x10-4 mol) were added at 
room temperature to the polymer support (resin) in DMF.  This was left to stir for 24 hours.  
Successful attachment was confirmed by a negative ninhydrin test.  The Fmoc group was cleaved 
by stirring the mixture in 20% (v/v) piperidine in DMF for 30 minutes.  Cleavage of the Fmoc 
group was confirmed by a positive ninhydrin test.  The Fmoc group was removed from the solution 
by filtration, followed by washing of the resin with isopropanol and DMF.  
6.17 Alternative method for coupling of Fmoc Alanines and Fmoc-tris amino acid 
The Fmoc Alanine (3 equivalents), DIPCDI (3 equivalents) and HATU (3 equivalents) were added 
at room temperature to the Seiber amide resin in DMF.  This was left to stir for 24 hours.  
Successful attachment was confirmed by a negative TNBS test.  All washings were done with 
DMF.  The Fmoc group was cleaved by stirring the mixture in a 20 % (v/v) piperidine in DMF for 
30 minutes.  Cleavage of the Fmoc group was confirmed by a positive TNBS test.   The Fmoc group 
was removed from the solution by filtration, followed by washing of the resin with isopropanol and 
DMF. 
6.18 Coupling of Fmoc tris amino acid fluoride (78) to the tri-peptide (69) bound to 
resin  
The Fmoc tris-amino acid fluoride 78 (0.67 g, 1.56x10-3 mol) and dry pyridine (151.00 µl, 1.87x10-3 
mol) was added to the resin in DMF and left to stir for 24 hours.  Successful attachment was 
confirmed by a negative ninhydrin test.   The Fmoc group was cleaved by stirring the mixture in a 
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20 % (v/v) piperidine in DMF for 30 minutes.  The Fmoc group was removed from the solution by 
filtration, followed by washing of the resin with isopropanol and DMF.‡‡ 
6.19 Cleavage of the tetra-peptide (79) from the resin and linker 
The supported peptide was separately washed with dichloromethane (3x10 ml), methanol (3x10 ml) 
and diethyl ether (3x10 ml) and dried overnight under vacuum.  The dry resin was placed in a flask 
containing the cleavage mixture of 95 % (v/v) TFA, 2.5 % (v/v) water and 2.5 % (v/v) 
triisopropylsilane.  The mixture was left to stir for 12 hours.  The resin was removed by filtration 
and washed several times with TFA.  The TFA was removed in vacuo at 40°C.  Higher 
temperatures can cleave the peptide bonds.166  A yellow oil remained.  The oil was dissolved in 
water and frozen with liquid nitrogen.  The solid peptide was obtained after freeze drying.  IR(KBr) 
vmax 3394 cm-1, 3298 cm-1, 2972 cm-1, 2880 cm-1, 1756 cm-1, 1677 cm-1, 1623 cm-1, 1548 cm-1, 1203 
cm-1.  Since the peptide  was not completely elucidated by NMR it is not easy to assign peaks, but 
carbonyl peaks appeared at 174, 172, 172 and 159 ppm. 
6.20 General procedure for HPLC analysis 
HPLC chromatography of 69, 79 and 80 was performed using a solvent system which was 80 % 
(v/v) acetonitrile/20 % (v/v) water/0.1 % (v/v) trifluoroacetic acid (solution A) and 100 % water 
(solution B). The following gradient elution system was used: 80 % solution A and 20 % solution B 
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